ReportWire

Tag: early days

  • Influencer Culture Drama ‘Early Days’ Unveils First Teaser Ahead of Red Sea Premiere (EXCLUSIVE)

    The first teaser has been unveiled for “Early Days,” a Mumbai-set drama about the perils of influencer culture that will world premiere at the Red Sea International Film Festival.

    The India-Singapore co-production, directed by feature directorial debutant Priyankar Patra, has been selected for the festival’s New Visions Competition, which runs Dec. 4-13 in Jeddah.

    The film marks a timely exploration of digital-age relationships, following a young couple thrust into social media visibility as they navigate love, ambition and economic survival in India’s most expensive city. Blending cinematic realism with the visual language of social media, “Early Days” captures what Patra describes as “what happens when life itself becomes performance.”

    “I wanted to tell a story that feels intimate but universal,” said Patra, whose previous credits include producing several international festival titles under the For Films banner.

    The project is executive produced by Aditya Vikram Sengupta, whose films “Labour of Love” won an award at Venice, while “Once Upon A Time In Calcutta,” where Patra was one of the producers, premiered there. Co-producers Isabella Sreyashii Sen and Olivier Dock, co-CEOs of Singapore’s Hazelnut Media, bring global distribution expertise to the project.

    “Priyankar’s voice is distinct and urgent,” Sengupta said. “This film captures our times with empathy and sharp observation.”

    The cast features newcomers Manasi Kaushik and Sarthak Sharma, with a creative team including editor-producer-composer Anupam Sinha Roy, sound designer Sukrit Sen and production designer Sayanika Mukherjee. Patra shot the film.

    Sen and Dock said they were drawn to how the film “interrogates the human cost of online aspiration —it’s both a deeply personal story and a quietly incisive social portrait.”

    For Films, based in Mumbai, focuses on character-driven cinema exploring intersections of technology, emotion and modern Indian life. Hazelnut Media specializes in impact production with a focus on cross-cultural storytelling.

    Watch the teaser here:

    Naman Ramachandran

    Source link

  • It’s Not the Economy. It’s the Pandemic.

    It’s Not the Economy. It’s the Pandemic.

    Sign up for The Decision, a newsletter featuring our 2024 election coverage.

    America is in a funk, and no one seems to know why. Unemployment rates are lower than they’ve been in half a century and the stock market is sky-high, but poll after poll shows that voters are disgruntled. President Joe Biden’s approval rating has been hovering in the high 30s. Americans’ satisfaction with their personal lives—a measure that usually dips in times of economic uncertainty—is at a near-record low, according to Gallup polling. And nearly half of Americans surveyed in January said they were worse off than three years prior.

    Experts have struggled to find a convincing explanation for this era of bad feelings. Maybe it’s the spate of inflation over the past couple of years, the immigration crisis at the border, or the brutal wars in Ukraine and Gaza. But even the people who claim to make sense of the political world acknowledge that these rational factors can’t fully account for America’s national malaise. We believe that’s because they’re overlooking a crucial factor.

    Four years ago, the country was brought to its knees by a world-historic disaster. COVID-19 hospitalized nearly 7 million Americans and killed more than a million; it’s still killing hundreds each week. It shut down schools and forced people into social isolation. Almost overnight, most of the country was thrown into a state of high anxiety—then, soon enough, grief and mourning. But the country has not come together to sufficiently acknowledge the tragedy it endured. As clinical psychiatrists, we see the effects of such emotional turmoil every day, and we know that when it’s not properly processed, it can result in a general sense of unhappiness and anger—exactly the negative emotional state that might lead a nation to misperceive its fortunes.

    The pressure to simply move on from the horrors of 2020 is strong. Who wouldn’t love to awaken from that nightmare and pretend it never happened? Besides, humans have a knack for sanitizing our most painful memories. In a 2009 study, participants did a remarkably poor job of remembering how they felt in the days after the 9/11 attacks, likely because those memories were filtered through their current emotional state. Likewise, a study published in Nature last year found that people’s recall of the severity of the 2020 COVID threat was biased by their attitudes toward vaccines months or years later.

    [From the May 2021 issue: You won’t remember the pandemic the way you think you will]

    When faced with an overwhelming and painful reality like COVID, forgetting can be useful—even, to a degree, healthy. It allows people to temporarily put aside their fear and distress, and focus on the pleasures and demands of everyday life, which restores a sense of control. That way, their losses do not define them, but instead become manageable.

    But consigning painful memories to the River Lethe also has clear drawbacks, especially as the months and years go by. Ignoring such experiences robs one of the opportunity to learn from them. In addition, negating painful memories and trying to proceed as if everything is normal contorts one’s emotional life and results in untoward effects. Researchers and clinicians working with combat veterans have shown how avoiding thinking or talking about an overwhelming and painful event can lead to free-floating sadness and anger, all of which can become attached to present circumstances. For example, if you met your old friend, a war veteran, at a café and accidentally knocked his coffee over, then he turned red and screamed at you, you’d understand that the mishap alone couldn’t be the reason for his outburst. No one could be that upset about spilled coffee—the real root of such rage must lie elsewhere. In this case, it might be untreated PTSD, which is characterized by a strong startle response and heightened emotional reactivity.

    We are not suggesting that the entire country has PTSD from COVID. In fact, the majority of people who are exposed to trauma do not go on to exhibit the symptoms of PTSD. But that doesn’t mean they aren’t deeply affected. In our lifetime, COVID posed an unprecedented threat in both its overwhelming scope and severity; it left most Americans unable to protect themselves and, at times, at a loss to comprehend what was happening. That meets the clinical definition of trauma: an overwhelming experience in which you are threatened with serious physical or psychological harm.

    [Read: Why are people nostalgic for early-pandemic life?]

    Traumatic memories are notable for how they alter the ways people recall the past and consider the future. A recent brain-imaging study showed that when people with a history of trauma were prompted to return to those horrific events, a part of the brain was activated that is normally employed when one thinks about oneself in the present. In other words, the study suggests that the traumatic memory, when retrieved, came forth as if it were being relived during the study. Traumatic memory doesn’t feel like a historical event, but returns in an eternal present, disconnected from its origin, leaving its bearer searching for an explanation. And right on cue, everyday life offers plenty of unpleasant things to blame for those feelings—errant friends, the price of groceries, or the leadership of the country.

    To come to terms with a traumatic experience, as clinicians know, you need to do more than ignore or simply recall it. Rather, you must rework the disconnected memory into a context, and thereby move it firmly into the past. It helps to have a narrative that makes sense of when, how, and why something transpired. For example, if you were mugged on a dark street and became fearful of the night, your therapist might suggest that you connect your general dread with the specifics of your assault. Then your terror would make sense and be restricted to that limited situation. Afterward, the more you ventured out in the dark, perhaps avoiding the dangerous block where you were jumped, the more you would form new, safe memories that would then serve to mitigate your anxiety.

    Many people don’t regularly recall the details of the early pandemic—how walking down a crowded street inspired terror, how sirens wailed like clockwork in cities, or how one had to worry about inadvertently killing grandparents when visiting them. But the feelings that that experience ignited are still very much alive. This can make it difficult to rationally assess the state of our lives and our country.

    One remedy is for leaders to encourage remembrance while providing accurate and trustworthy information about both the past and the present. In the early days of the pandemic, President Donald Trump mishandled the crisis and peddled misinformation about COVID. But with 2020 a traumatic blur, Trump seems to have become the beneficiary of our collective amnesia, and Biden the repository for lingering emotional discontent. Some of that misattribution could be addressed by returning to the shattering events of the past four years and remembering what Americans went through. This process of recall is emotionally cathartic, and if it’s done right, it can even help to replace distorted memories with more accurate ones.

    President Biden invited the nation to grieve together in 2021, when American death counts reached 500,000, and again in 2022, when they surpassed 1 million. In his 2022 State of the Union address, he rightly acknowledged that “we meet tonight in an America that has lived through two of the hardest years this nation has ever faced,” before urging Americans to “move forward safely.” But in the past two years, he, like almost everyone else, has largely tried to proceed as if everyone is back to normal. Meanwhile, American minds and hearts simply aren’t ready—whether we realize it or not.

    [Read: The Biden administration killed America’s collective pandemic approach]

    Perhaps Biden and his advisers fear that reminding voters of such a dark time would create more trouble for his presidency. And yet, our work leads us to believe that the effect would be exactly the opposite. Rituals of mourning and remembrance help people come together and share in their grief so that they can return more clear-eyed to face daily life. By prompting Americans to remember what we endured together, paradoxically, Biden could help free all of us to more fully experience the present.

    George Makari

    Source link

  • The ‘Anti-Defeat’ Candidate

    The ‘Anti-Defeat’ Candidate

    Like many politicians, Representative Dean Phillips likes to look people in the eye. And because he’s a politician, Phillips can glean things, just as President George W. Bush did when he peered into Vladimir Putin’s eyes and saw his soul.

    “I’ve looked Benjamin Netanyahu in the eye,” Phillips told a group of students at Dartmouth College, in Hanover, New Hampshire, last week.

    And?

    “I did not like what I saw,” Phillips said of the Israeli prime minister. “I do not like his government. He’s got to go.”

    Philips has also looked into Donald Trump’s eyes. That, too, was ominous. It was a few years ago, and the former president had invited a bunch of new House members to the White House for an introductory visit.

    “I looked him in the eye for the better part of an hour,” Phillips told me.

    And?

    “I saw right through him,” Phillips said. “I know exactly how to handle weaklings like Donald Trump.”

    How?

    “You’ll see,” he said. “Why would I give away my special sauce?”

    Phillips was telling me this while tucked into the back of a minivan, having just set off on a 90-minute ride from Hanover to Manchester. He wore a down vest over a blue dress shirt and looked me straight in the you-know-what as he described the “gravity of this entire circumstance” he was now embarked upon.

    He had just concluded one of his early days as an official primary challenger to President Joe Biden, the incumbent he must first dispatch before he can douse Trump with his proprietary Dean Sauce. Phillips is pursuing this mission despite long odds and an unsurprising chorus of how dare yous and not helpfuls from various Democratic gatekeepers. He has already said plenty about why he is doing this—about how Democrats are desperate for a Plan B to Biden, who Phillips says has no business seeking reelection at his age (81 on Monday), with his poll numbers and the catastrophic threat of his likely GOP opponent (yes, him). Phillips agonized over his decision and unburdened himself in multiple forums, including, quite expansively last month, to my colleague Tim Alberta.

    I was in New Hampshire because I wanted to see Phillips transition from theoretical to actual challenger. It is one thing to scream warnings about alarming data, and another to segue into the granular doings of a campaign. “This is an all-hands-on-deck initiative,” he told me, his words landing somewhere between hyper-earnest and naive, with occasional tips into grandiose. Phillips, 54, is a figure of uncommonly big plans and weighty burdens, especially given his relatively modest station (he has represented Minnesota’s Third Congressional District since 2019). He seems sincere about what he’s doing, especially compared with the two-faced default of so many elected Democrats who tout Biden’s reelection in public while privately pining for some other candidate, like Gretchen Whitmer, the Rock, or whomever they want instead. In this sense, Phillips’s gambit is noble, even necessary. It can also be lonely and awkward to watch up close.

    Since entering the race a month ago, Phillips has held a series of mostly low-key events in New Hampshire and has made a stop in South Carolina. I first encountered him during a heartfelt give-and-take with half a dozen members of the Dartmouth Political Union. “This is a beautiful American moment,” Phillips declared after a dialogue about abortion policy with a polite young Nikki Haley supporter. Later, at a town hall across campus, Phillips described that bridge-building exchange as “one of the most profound hours of engagement” he’s had in a long while and something “I will remember for years to come.”

    Phillips told me that his initial campaign forays have only—surprise—reaffirmed the premise of his errand: “Other than some Democratic elected officials, and only a few of them, I’ve not yet encountered a single person who doesn’t feel the same way,” he said, about the need for a Biden alternative. His go-to weapon against the president is public opinion, for which Phillips keeps getting fresh ammunition. “I want to give you some simple data,” he said during a meet and greet with about 50 students, faculty, and community members before the town hall. He mentioned a recent survey of voters in battleground states that had Biden trailing Trump by four points, 48–44. “But then you look at how Trump does against a ‘generic Democrat,’” Phillips said, “and the generic Democrat wins 48–40.” Heads bobbed in the classroom; Phillips shook his in exasperation.

    Phillips himself is polling at just 10 percent among likely New Hampshire Democratic-primary voters, according to a CNN survey released last week that had Biden at 65 percent. During our car ride, I suggested to Phillips that maybe he should change his name to “Generic Democrat.”

    “I never in my life aspired to be generic,” he replied, chuckling.

    Primary challenges to incumbent presidents have historically been associated with signature causes and fiery rhetoric. They tend to be ideologically driven—such as Ted Kennedy’s challenge to President Jimmy Carter from the left in 1980 and Pat Buchanan’s to President George H. W. Bush from the right in 1992. No one will mistake Phillips for a brawling populist. He is affable, well mannered, and extremely rich, with a net worth of about $50 million, some portion of it derived from the gelato-and-sorbet company—Talenti—that he co-owned before it was sold.

    Still, Phillips frequently brings up the late Senator Eugene McCarthy, a fellow Minnesota Democrat, whose uprising against President Lyndon B. Johnson in 1968 helped push Johnson to not seek reelection. The comparison is fraught in that Democrats wound up nominating another Minnesotan, Hubert Humphrey, who went on to lose to Richard Nixon. Carter and Bush also lost their general elections. This tends to be the main critique of Phillips: that his project could weaken Biden against Trump.

    One student at Dartmouth questioned Phillips about the 1980 example, arguing that Kennedy was the reason that Carter was ultimately blown out by Ronald Reagan. Phillips came back with a lengthy and somewhat defensive response. “Ted Kennedy didn’t cause Carter’s problems any more than I’ve caused Joe Biden’s problems,” he said. The student nodded and thanked the candidate, who in turn thanked the student—and another beautiful American moment was forged.

    “I am the anti-defeat candidate,” Phillips said, describing his enterprise to me later. “I am the truth-telling candidate.” “Truth-telling” is of course subjective, in campaigns as in life. Phillips then told me about a visit he’d made to a Hanover restaurant that day. After a series of “wonderful conversations” with random diners, he’d encountered a young woman who “I sensed was not showing any compassion for butchered Israelis”—a reference to the Hamas attacks on October 7. So Phillips, who is Jewish, paused the conversation and asked a question of his own. “I said, ‘Are you telling me that you support Hamas?’” Phillips said. “And she goes, ‘Yes.’” At which point, he’d heard enough.

    “I said, ‘Look, I really enjoyed our conversation, but I can’t continue this.’”

    “Wait, did you really enjoy that conversation?” I interrupted, questioning his truth-telling.

    “I’ll tell you what, that’s a good point,” Phillips acknowledged. “I did not enjoy it.”

    In that spirit of engaging with people of different backgrounds and persuasions, Phillips frequently invokes his friendship with Rashida Tlaib, the only Palestinian American in Congress, who was censured by the House this month for her comments about Israel. Phillips refers to Tlaib as “my Palestinian sister” and to himself as “her Jewish brother.”

    I pressed Phillips on the state of his relations with Tlaib. “It’s as difficult as ever and more important than ever,” he said. He then raised the stakes even higher. “I believe that as Rashida Tlaib and Dean Phillips go, so will the Middle East,” he said. (A lot of pressure there!)

    As our nighttime ride persisted southeast down Interstate 89, the conversation took some quick turns.

    “Is Kamala Harris prepared to step in if something happened to Biden?” I asked Phillips.

    “I think that Americans have made the decision that she’s not,” he said.

    I replied that I was interested in the decision of one specific American, Dean Phillips.

    “That is not my opinion,” Phillips clarified. He said that every interaction he’s had with the vice president has been “thoughtful” and that “I’ve enjoyed them.”

    “That said …” Phillips paused, and I braced for the vibe shift.

    “I hear from others who know her a lot better than I do that many think she’s not well positioned,” he said of Harris. “She is not well prepared, doesn’t have the right disposition and the right competencies to execute that office.” Phillips also noted that Harris’s approval numbers are even worse than Biden’s: “It’s pretty clear that she’s not somebody people have faith in.”

    But again, Phillips is not one of those people: “From my personal experiences, I’ve not seen those deficiencies.”

    If Phillips had looked me in the eye at that moment—and granted, it was dark in the back of the van—he would have seen a slightly confused expression. Why was he hiding behind these Trumplike “many people are saying” attributions? Similarly, he often speaks in glowing terms about Biden’s performance in office—“his administration has been quite extraordinary”—while leaning heavily on “the opinion of others” or “the data” to make his case that the president himself needs to go. Phillips can seem torn at times as he attempts to hedge his way through somewhat contradictory impulses: to give Biden his proper due while also trying to end his career.

    I asked Phillips what would happen if his campaign really takes off—he wins a bunch of primaries—and then Biden tries to placate the insurgents by dumping Harris in favor of their hero, Dean Phillips. Would he agree to serve as Biden’s new understudy?

    I anticipated the “I’m not answering hypothetical questions” blow-off that they teach in Candidate School. But Phillips apparently skipped class that day. “That’s a really interesting question,” he said, before letting me down gently.

    “President Biden will never replace Vice President Harris on the ticket, ever,” he said.

    For the record—bonus nugget—Phillips predicts that Trump will select Robert F. Kennedy Jr. to be his running mate. “And they will be very difficult to beat,” he fears. These are the kinds of empty punditing calories that get passed around during long drives on chilly campaign nights.

    As we approached Manchester, Phillips flashed back to reality, or something. “I am the best positioned to defeat Donald Trump,” he said. “All I’m focused on right now is to run a spirited, thoughtful, and energetic campaign.”

    “What about ‘vigorous’ and ‘robust’?” I asked.

    “Yes, yes,” Phillips said, nodding. It was getting late, and we were both getting a bit punchy.

    “And bold,” he added.

    Our van pulled into the Manchester DoubleTree just before 10 p.m. Phillips had to wake up in a few hours to catch a 6:15 a.m. flight back to Washington. He looked me in the eye. I’m not sure what he saw, or what I saw, but I wished him luck.

    “I’ve enjoyed this,” Phillips said.

    Mark Leibovich

    Source link

  • Nixon Between the Lines

    Nixon Between the Lines

    Call it coincidence, serendipity, an aligning of the planets—whatever the term, the moment was creepy and amusing all at once. I was beavering away in the basement research room at the Richard Nixon Presidential Library and Museum, in Yorba Linda, a suburb of Los Angeles, when Henry Kissinger twice came into view—in the flat, cursive form of Nixon’s scrawl in the margins of the book I was reading, and then in the rounder corporeal form of the man himself, in the hallway outside the door.

    Explore the October 2023 Issue

    Check out more from this issue and find your next story to read.

    View More

    Kissinger, the last surviving member of Nixon’s Cabinet, was in Yorba Linda last fall for two reasons: to speak at a fundraising gala for the Richard Nixon Foundation and to promote a book he had published earlier in the year, at the improbable age of 99. The book, Leadership, contains an entire chapter in praise of Nixon, the man who had made Kissinger the 20th century’s only celebrity diplomat.

    I was there to gather material for a Nixon book of my own. I had been nosing around in a cache of volumes from Nixon’s personal library. I was particularly interested in any marks he may have left in the books he’d owned. From what I could tell, no one had yet mined this remarkably varied collection, more than 2,000 books filling roughly 160 boxes stored in a vault beneath the presidential museum. Taken together, they reflect the broad range of Nixon’s intellectual curiosity—an underappreciated quality of his highly active mind. To give an idea: One heavily underlined book in the collection is a lengthy biography of Tolstoy; another is a book on statesmanship by Charles de Gaulle; another is a deep dive into the historiography of Japanese art. Several fat volumes of The Story of Civilization, Will and Ariel Durant’s mid-century monument to middlebrow history, display evidence of attentive reading and rereading.

    Every morning a friendly factotum would wheel out a gray metal cart stacked with dusty boxes from Nixon’s personal library. On the afternoon Kissinger arrived, I had worked my way down to an obscure book published in 1984, a decade after Nixon left the White House. A significant portion of Bad News: The Foreign Policy of The New York Times, by a foreign correspondent for the New York Daily News named Russ Braley, is a blistering indictment of the Times’ coverage of the Nixon administration. In Braley’s telling, the Times’ treatment swung between the unfair and the uncomprehending, for reasons ranging from negligence to malice.

    The book had found its ideal reader in Richard Nixon. The pages of his copy were cluttered with underlining from his thick ballpoint pen. It occurred to me, as I followed along, that Nixon was being brought up short by his reading: Much of the material in Bad News was apparently news to him.

    My reading was interrupted by a commotion outside the research room. I stuck my head out in time to see Kissinger and his entourage settling into the room across the hall. A group of donors and Nixonophiles had gathered to hear heroic tales of Nixon’s statecraft.

    I dutifully returned to Braley. When I got to a chapter on Daniel Ellsberg and the Pentagon Papers, I found an unmistakable pattern: Most of Nixon’s markings involved the man holding court across the hall. And Nixon wasn’t happy with him. Kissinger, Braley wrote, had actually invited Ellsberg to Nixon’s transition office in late 1968 to explicate his dovish views on Vietnam, more than two years before the Papers were released. Nixon’s pen came down: exclamation point! Kissinger gave Ellsberg an office in the White House complex anyway, for a month in 1969—a stone’s throw from the Oval Office. Slash mark! Kissinger spent his evenings “ridicul[ing]” Nixon “in private conversations with liberal friends.” This last treachery summoned the full battery of Nixon’s marginalia: a slash running alongside the paragraph, a check mark for emphasis, and a plump, emphatic line under “liberal friends.”

    photo of a book's page with text underlined in blue pen and hand-written brackets and !! notations in margin
    Page 551 from Bad News: The Foreign Policy of The New York Times, by Russ Braley (Photograph by Joel Barhamand for The Atlantic)

    Still, Braley went on, when the Pentagon Papers were leaked, their publication alarmed Kissinger, because they posed a “double threat” to national security and to the conduct of foreign policy. “And to K!” Nixon wrote in the margin.

    The contrast between Nixon’s bitter hash marks about Kissinger from the 1980s and Kissinger’s present-day celebration of his old boss offered a lesson in the evolving calculation of self-interest. It also conjured the image of a solitary old man in semiretirement, learning things about a now-vanished world he’d once thought he presided over. It happened often in the reading room in Yorba Linda: With unexpected immediacy, the gray metal cart carried the past into the present, in small but tangible fragments of Nixon himself.

    The task of a marginalia maven is at right angles to the task of reading a book: It is an attempt to read the reader rather than to read the writer. For several decades now, scholars have been swarming the margins of books in dead people’s libraries. Those margins are among the most promising sites of “textual activity,” to use the scholar’s clinical phrase—a place to explore, analyze, and, it is hoped, find new raw material for the writing of dissertations. Famous readers whose libraries have fallen under such scrutiny include Melville and Montaigne, Machiavelli and Mark Twain.

    A book invites various kinds of engagement, depending on the reader. Voltaire (whom Nixon admired, to judge by his extravagant underlining in the Durants’ The Age of Voltaire) scribbled commentary so incessantly that his marginalia have been published in volumes of their own. Voltaire liked to argue with a book. Nixon did not. He had a lively mind but not, when reading, a disputatious one; he restricted his marginalia almost exclusively to underlining sentences or making other subverbal marks on the page—boxes and brackets and circles. You get the idea that he knew what he wanted from a book and went searching for it, and when he found what he wanted, he pinned it to the page with his pen (seldom, from what I’ve seen, a pencil).

    In his method, Nixon resembled the English writer Paul Johnson. I once asked Johnson how, given his prolific journalistic career—several columns and reviews a week in British and American publications—he managed to read all the books he cited in his own very long and very readable histories, which embraced such expansive subjects as Christianity, ancient Egypt, and the British empire. His reaction bordered on revulsion at my naivete. “Read them?!” he spat out. “Read them?! I don’t read them! I fillet them!” As it happens, Nixon was an avid reader of Johnson, whose books he often handed out to friends and staff at Christmastime.

    John Adams, another busy producer of marginalia, liked to quote a Latin epigram: Studium sine calamo somnium. Adams translated this as: “Study without a pen in your hand is but a dream.” Nixon acquired the pen-in-hand habit early, as his surviving college and high-school textbooks show, and he kept at it throughout his life. For Nixon, as for the rest of us, marking up books was also a way of slowing himself down and attending to what he read. He was not a notably fast reader, by his own account, but his powers of concentration and memorization were considerable. Going at a book physically was a way of absorbing it mentally.

    One of the most heavily represented authors in Nixon’s personal library is Churchill, whom Nixon revered not only as a statesman but also as a historian and an essayist. Nixon’s shelves sagged with Churchill’s multivolume histories and biographies: The World Crisis, Marlborough: His Life and Times, The Second World War, A History of the English Speaking Peoples. Churchill’s Great Contemporaries, a series of sketches he wrote in the 1920s and ’30s sizing up roughly two dozen friends and colleagues, was clearly a favorite. When I retrieved Nixon’s copy from a box, I found it dog-eared throughout.

    Nixon’s tastes ran heavily toward history, but he could be tempted away from the past to a book of present-day punditry, if the writer and point of view were agreeable. According to a report in Time magazine, when half a million citizens descended on Washington, D.C., in November 1969 to protest the Vietnam War, Nixon holed up in his private quarters with a book called The Decline of Radicalism: Reflections on America Today. The book, slim and elegant, had been sent to Nixon by its author, the historian Daniel Boorstin.

    Judging by his notations, Nixon was interested less in Boorstin’s turgid cultural analysis of “consumption communities” and more in his thesis that the ragged protesters gathering outside the White House fence constituted something new in American history: They were not radicals at all but nihilists. Nixon brought out the pen, and in Yorba Linda, a continent and decades away from his White House hideaway, I could still feel the insistent furrow of his underlining on the page. He marked several consecutive paragraphs in a section called “The New Barbarians,” in which Boorstin criticized protesters for their “indolence of mind” and “mindless, obsessive quest for power.”

    People read books for lots of reasons: instruction, pleasure, uplift. This was Nixon reading for self-defense.

    The book I most wanted to see in Yorba Linda was Nixon’s copy of Robert Blake’s biography Disraeli (1966). A re-creation of Nixon’s favorite room in the White House was one of the Nixon museum’s prime exhibits when it opened, in 1990, a few years before Nixon’s death. (It has since been redesigned.) Nixon himself chose Disraeli to rest on his desk for the public to see. The book was given to him during his first year in the White House, in 1969, by Daniel Patrick Moynihan, a Harvard professor, prominent Democrat, and future U.S. senator from New York. To the surprise of just about everybody, the year he took office, Nixon made Moynihan his chief domestic-policy counselor, a counterpart in those early days to Kissinger as head of the National Security Council. Despite Nixon’s enduring image as a black-eyed right-winger, his political ideology was always flexible, if not flatly self-contradictory.

    Moynihan the liberal hoped to persuade Nixon the hybrid to take Benjamin Disraeli, the great prime minister of Victorian Britain, as his model. Disraeli was a Tory and an imperialist, and at the same time a social reformer of vision and courage. According to Moynihan, Nixon read the book within days of receiving it. Soon enough, the president was calling himself a “Disraeli conservative.” The precise meaning of the tag was clear to Nixon alone, but we can assume it underwent a great deal of improvisation and revision as his presidency wore on.

    Disraeli’s appeal to Nixon went beyond his light-footed ideology. Speaking to his Cabinet at a dinner one evening in early 1972, Nixon called Disraeli a “magnificent” politician. Now, he went on, the “fashionable set today would immediately say, ‘Ah, politicians. Bad.’ ” As he saw it, the “fashionable set”—the epithet, suffused with reverse snobbery and class resentment, is pure Nixon—believed that politicians disdain idealism and think nothing of principle. “But,” Nixon said, “the pages of history are full of idealists who never accomplished anything.” It was “pragmatic men” like Disraeli “who had the ability to do things that other people only talked about.” Nixon, who had never shied away from calling himself a politician, wanted to see himself in Disraeli, or at least in Blake’s Disraeli—this “classic biography,” to which, he told his Cabinet, he often turned for inspiration on sleepless nights. And here the book was, Nixon’s own copy, at the top of my growing stack in Yorba Linda.

    Disraeli is packed with observations about political tradecraft. They are penetrating, specific, and cold-blooded. The little dicta come from both the biographer and his subject. “He was a master at disguising retreat as advance,” Blake wrote approvingly. Nixon underlined that sentence, and then this one from Disraeli’s contemporary Lord Salisbury: “The commonest error in politics is sticking to the carcasses of dead policies.”

    A line, a check mark, a circle—why Nixon deployed one notation and not another for any given passage is a question as unanswerable as “Why didn’t he burn the tapes?” But it was politics that always caught his eye, and activated his pen. Disraeli, Blake wrote, “suffered from a defect, endemic among politicians, the greatest reluctance to admit publicly that he had been in the wrong, even when the fault lay with his subordinates.” Another from Blake: Successful politicians “realize that a large part of political life in a parliamentary democracy consists not so much in doing things yourself as in imparting the right tone to things that others do for you or to things that are going to happen anyway.”

    Should we take marked passages like these, with their ironic acceptance of the fudging and misdirection called for in the political arts, as a gesture toward self-criticism on Nixon’s part? Probably not: Nixon knew himself better than psycho-biographers give him credit for, but self-awareness is not self-criticism. In his chosen profession, he took the bad with the good, and his casual, creeping concessions to the seamier requirements of politics are what eventually did him in.

    If you go looking for them, you can see reflections of Blake’s Disraeli throughout Nixon’s presidency, encapsulated in enduring phrases here and there. It was in Blake that Nixon came across Disraeli’s famous description of “exhausted volcanoes.” Disraeli coined it to disparage the feckless time-servers in William Ewart Gladstone’s cabinet after they had been in office a few years. Nixon underscored not only “exhausted volcanoes” but the rest of the passage from Blake’s text: The phrase, Blake writes, “was no mere gibe … For the past year, the Government had been vexed by that combination of accidents, scandals and blunders which so often for no apparent reason seem to beset an energetic administration in its later stages.”

    Nixon feared the same fate for his second term—a loss of energy and direction. The day after his landslide reelection, in 1972, he called together his Cabinet and senior staff. He told them of Disraeli’s warning about “exhausted volcanoes.” And then, with his chief of staff, H. R. Haldeman, serving as the lord high executioner, he demanded their resignations en masse.

    Not everything in Blake’s Disraeli caught Nixon’s interest; certainly not everything was useful to him. As I paged through, I saw there were many longueurs, stretches of several dozen pages, sometimes more, where no filleting of any kind happened. And then—inevitably, suddenly—Nixon the reader is seized by passages of sometimes thunderous resonance, and the pen is again called into play.

    “Disraeli,” Blake writes, “really was regarded as an outsider by the Victorian governing class.” One can almost see Nixon sit bolt upright and pick up his pen. This is the same ostracism that Nixon himself felt keenly throughout his personal and professional life, in fact and in imagination. The following page and a half, discussing the disdain of the “élite” for Disraeli, is bracketed nearly in its entirety. Some sentences are boxed. Some passages, like this one, are underlined as well as bracketed:

    Men of genius operating in a parliamentary democracy … inspired a great deal of dislike and no small degree of distrust among the bustling mediocrities who form the majority of mankind.

    The antagonism of the elites was not the determining fact of Disraeli’s career, but both biographer and subject perceived its profound effects, and so did the man reading about it 90 years after Disraeli’s death. As president, Nixon felt himself similarly situated: the political leader of an imperial nation, highly skilled, aching for greatness, yet in permanent estrangement from the most powerful figures of the politics and culture that surrounded him, nearly all of whom he judged, as Disraeli had, “bustling mediocrities.”

    When reading about the elites, Nixon pressed the ballpoint deep into the page. We marginalia mavens, tracing our fingers across the lines today, can only guess, of course. But it may be that in 1969, sitting in the reading chair in his White House hideaway, he already sensed that this was not bound to end well.


    This article appears in the October 2023 print edition with the headline “Nixon Between the Lines.” When you buy a book using a link on this page, we receive a commission. Thank you for supporting The Atlantic.

    Andrew Ferguson

    Source link

  • The Big COVID Question for Hospitals This Fall

    The Big COVID Question for Hospitals This Fall

    Back in the spring, around the end of the COVID-19 public-health emergency, hospitals around the country underwent a change in dress code. The masks that staff had been wearing at work for more than three years vanished, in some places overnight. At UChicago Medicine, where masking policies softened at the end of May, Emily Landon, the executive medical director of infection prevention and control, fielded hate mail from colleagues, some chiding her for waiting too long to lift the requirement, others accusing her of imperiling the immunocompromised. At Vanderbilt University Medical Center, which did away with masking in April, ahead of many institutions, Tom Talbot, the chief hospital epidemiologist, was inundated with thank-yous. “People were ready; they were tired,” he told me. “They’d been asking for several months before that, ‘Can we not stop?’”

    But across hospitals and policies, infection-prevention experts shared one sentiment: They felt almost certain that the masks would need to return, likely by the end of the calendar year. The big question was exactly when.

    For some hospitals, the answer is now. In recent weeks, as COVID-19 hospitalizations have been rising nationwide, stricter masking requirements have returned to a smattering of hospitals in Massachusetts, California, and New York. But what’s happening around the country is hardly uniform. The coming respiratory-virus season will be the country’s first after the end of the public-health emergency—its first, since the arrival of COVID, without crisis-caliber funding set aside, routine tracking of community spread, and health-care precautions already in place. After years of fighting COVID in concert, hospitals are back to going it alone.

    A return to masking has a clear logic in hospitals. Sick patients come into close contact; medical procedures produce aerosols. “It’s a perfect storm for potential transmission of microbes,” Costi David Sifri, the director of hospital epidemiology at UVA Health, told me. Hospitals are on the front lines of disease response: They, more than nearly any other place, must prioritize protecting society’s vulnerable. And with one more deadly respiratory virus now in winter’s repertoire, precautions should logically increase in lockstep. But “there is no clear answer on how to do this right,” says Cameron Wolfe, an infectious-disease physician at Duke. Americans have already staked out their stances on masks, and now hospitals have to operate within those confines.


    When hospitals moved away from masking this spring, they each did so at their own pace—and settled on very different baselines. Like many other hospitals in Massachusetts, Brigham and Women’s Hospital dropped its mask mandate on May 12, the day the public-health emergency expired; “it was a noticeable difference, just walking around the hospital” that day, Meghan Baker, a hospital epidemiologist for both Brigham and Women’s Hospital and Dana-Farber Cancer Institute, told me. UVA Health, meanwhile, weaned staff off of universal masking over the course of about 10 weeks.

    Most masks at the Brigham are now donned on only a case-by-case basis: when a patient has active respiratory symptoms, say, or when a health-care worker has been recently sick or exposed to the coronavirus. Staff also still mask around the same subset of vulnerable patients that received extra protection before the pandemic, including bone-marrow-transplant patients and others who are highly immunocompromised, says Chanu Rhee, an associate hospital epidemiologist at Brigham and Women’s Hospital. UVA Health, meanwhile, is requiring masks for everyone in the hospital’s highest-risk areas—among them, certain intensive-care units, as well as cancer, transplant, and infusion wards. And although Brigham patients can always request that their providers mask, at UVA, all patients are asked upon admission whether they’d like hospital staff to mask.

    Nearly every expert I spoke with told me they expected that masks would at some point come back. But unlike the early days of the pandemic, “there is basically no guidance from the top now,” Saskia Popescu, an epidemiologist and infection-prevention expert at the University of Maryland School of Medicine, said. The CDC still has a webpage with advice on when to mask. Those recommendations are tailored to the general public, though—and don’t advise covering up until COVID hospital admissions go “way high, when the horse has well and truly left the barn,” Landon, at UChicago, told me. “In health care, we need to do something before that”—tamping down transmission prior to wards filling up.

    More specific advice could still emerge from the CDC, or individual state health departments. But going forward, the assumption is that “each hospital is supposed to have its own general plan,” Rhee told me. (I reached out to the CDC repeatedly about whether it might update its infection-prevention-guidance webpage for COVID—last retooled in May—but didn’t receive a response.)

    Which leaves hospitals with one of two possible paths. They could schedule a start to masking season, based on when they estimate cases might rise—or they could react to data as they come in, tying masking policies to transmission bumps. With SARS-CoV-2 still so unpredictable, many hospitals are opting for the latter. That also means defining a true case rise—“what I think everybody is struggling with right now,” Rhee said. There is no universal definition, still, for what constitutes a surge. And with more immunity layered over the population, fewer infections are resulting in severe disease and death—even, to a limited extent, long COVID—making numbers that might have triggered mitigations just a year or two ago now less urgent catalysts.

    Further clouding the forecast is the fact that much of the data that experts once relied on to monitor COVID in the community have faded away. In most parts of the country, COVID cases are no longer regularly tallied; people are either not testing, or testing only at home. Wastewater surveillance and systems that track all influenza-like illnesses could provide some support. But that’s not a whole lot to go on, especially in parts of the country such as Tennessee, where sewage isn’t as closely tracked, Tom Talbot, of Vanderbilt, told me.

    Some hospitals have turned instead to in-house stats. At Duke—which has adopted a mitigation policy that’s very similar to UVA’s—Wolfe has mulled pulling the more-masking lever when respiratory viruses account for 2 to 4 percent of emergency and urgent-care visits; at UVA, Sifri has considered taking action once 1 or 2 percent of employees call out sick, with the aim of staunching sickness and preserving staff. “It really doesn’t take much to have an impact on our ability to maintain operations,” Sifri told me. But “I don’t know if those are the right numbers.” Plus, internal metrics are now tricky for the same reasons they’ve gotten shaky elsewhere, says Xiaoyan Song, the chief infection-control officer at Children’s National Hospital, in Washington, D.C. Screening is no longer routine for patients, skewing positivity stats; even sniffly health-care workers, several experts told me, are now less eager to test and report.

    For hospitals that have maintained a more masky baseline, scenarios in which universal masking returns are a little easier to envision and enact. At UChicago Medicine, Landon and her colleagues have developed a color-coded system that begins at teal—masking for high-risk patients, patients who request masked care, and anyone with symptoms, plus masking in high-risk areas—and goes through everyone-mask-up-everywhere red; their team plans to meet weekly to assess the situation, based on a variety of community and internal metrics, and march their masking up or down. Wolfe, of Duke, told me that his hospital “wanted to reserve a little bit of extra masking quite intentionally,” so that any shift back toward stricter standards would feel like less of a shock: Habits are hard to break and then reform.

    Other hospitals that have been living mostly maskless for months, though, have a longer road back to universal masking, and staff members who might not be game for the trek. Should masks need to return at the Brigham or Dana-Farber, for instance, “I suspect the reaction will be mixed,” Baker told me. “So we really are trying to be judicious.” The hospital might try to preserve some maskless zones in offices and waiting rooms, for instance, or lower-risk rooms. And at Children’s National, which has also largely done away with masks, Song plans to follow the local health department’s lead. “Once D.C. Health requires hospitals to reimplement the universal-masking policy,” she told me, “we will be implementing it too.”

    Other mitigations are on the table. Several hospital epidemiologists told me they expected to reimplement some degree of asymptomatic screening for various viruses around the same time they reinstate masks. But measures such as visiting restrictions are a tougher call. Wolfe is reluctant to pull that lever before he absolutely has to: Going through a hospital stay alone is one of the “harder things for patients to endure.”


    A bespoke approach to hospital masking isn’t impractical. COVID waves won’t happen synchronously across communities, and so perhaps neither should policies. But hospitals that lack the resources to keep tabs on viral spread will likely be at a disadvantage, and Popescu told me she worries that “we’re going to see significant transmission” in the very institutions least equipped to handle such influx. Even the best-resourced places may hit stumbling blocks: Many are still reeling from three-plus years of crisis and are dealing with nursing shortages and worker burnout.

    Coordination hasn’t entirely gone away. In North Carolina, Duke is working with the University of North Carolina at Chapel Hill and North Carolina State University to shift policies in tandem; in Washington State, several regional health-care organizations have pledged to align their masking policies. And the Veterans Health Administration—where masking remains required in high-risk units—has developed a playbook for augmenting mitigations across its many facilities, which together make up the country’s largest integrated health-care system, says Shereef Elnahal, the undersecretary of Veterans Affairs for health. Still, institutions can struggle to move in sync: Attitudes on masking aren’t exactly universal across health-care providers, even within a hospital.

    The country’s experience with COVID has made hospitals that much more attuned to the impacts of infectious disease. Before the pandemic began, Talbot said, masking was a rarity in his hospital, even around high-risk patients; many employees would go on shifts sick. “We were pretty complacent about influenza,” he told me. “People could come to work and spread it.” Now hospital workers hold themselves to a stricter standard. At the same time, they have become intimately attuned to the drawbacks of constant masking: Some have complained that masks interfere with communication, especially for patients who are young or hard of hearing, or who have a language barrier. “I do think you lose a little bit of that personal bonding,” Talbot said. And prior to the lifting of universal masking at Vanderbilt, he said, some staff were telling him that one out of 10 times they’d ask a patient or family to mask, the exchange would “get antagonistic.”

    When lifting mandates, many of the hospital epidemiologists I spoke with were careful to message to colleagues that the situation was fluid: “We’re suspending universal masking temporarily,” as Landon put it to her colleagues. Still, she admits that she felt uncomfortable returning to a low-mask norm at all. (When she informally polled nearly two dozen other hospital epidemiologists around the country in the spring, most of them told her that they felt the same.) Health-care settings aren’t meant to look like the rest of the world; they are places where precautions are expected to go above and beyond. COVID’s arrival had cemented masks’ ability to stop respiratory spread in close quarters; removing them felt to Landon like pushing those data aside, and putting the onus on patients—particularly those already less likely to advocate for themselves—to account for their own protection.

    She can still imagine a United States in which a pandemic-era response solidified, as it has in several other countries, into a peacetime norm: where wearing masks would have remained as routine as donning gloves while drawing blood, a tangible symbol of pandemic lessons learned. Instead, many American hospitals will be entering their fourth COVID winter looking a lot like they did in early 2020—when the virus surprised us, when our defenses were down.

    Katherine J. Wu

    Source link

  • The Republican Lab-Leak Circus Makes One Important Point

    The Republican Lab-Leak Circus Makes One Important Point

    For more than three hours yesterday, the House Select Subcommittee on the Coronavirus Pandemic grilled a pair of virologists about their participation in an alleged “cover-up” of the pandemic’s origins. Republican lawmakers zeroed in on evidence that the witnesses, Kristian Andersen and Robert Garry, and other researchers had initially suspected that the coronavirus spread from a Chinese lab. “Accidental escape is in fact highly likely—it’s not some fringe theory,” Andersen wrote in a Slack message to a colleague on February 2, 2020. When he laid out the same concern to Anthony Fauci in late January, that some features of the viral genome looked like they might be engineered, Fauci told him to consider going to the FBI.

    But days later, Andersen, Garry, and the other scientists were starting to coalesce around a different point of view: Those features were more likely to have developed via natural evolution. The scientists wrote up this revised assessment in an influential paper, published in the journal Nature Medicine in March 2020, called “The Proximal Origin of SARS-CoV-2.” The virus is clearly “not a laboratory construct or a purposefully manipulated virus,” the paper said; in fact, the experts now “did not believe that any type of laboratory-based scenario is plausible,” and that the pandemic almost certainly started with a “zoonotic event”—which is to say, the spillover of an animal virus into human populations. That analysis would be cited repeatedly by scientists and media outlets in the months that followed, in support of the idea that the lab-leak theory had been thoroughly debunked.

    The researchers’ rapid and consequential change of heart, as revealed through emails, witness interviews, and Slack exchanges, is now a wellspring for Republicans’ suspicions. “All of a sudden, you did a 180,” Representative Nicole Malliotakis of New York said yesterday morning. “What happened?”

    Based on the available facts, the answer seems clear enough: Andersen, Garry, and the others looked more closely at the data, and decided that their fears about a lab leak had been unwarranted; the viral features were simply not as weird as they’d first thought. The political conversation around this episode is not so easily summarized, however. Yesterday’s hearing was less preoccupied with the small, persistent possibility that the coronavirus really did leak out from a lab than with the notion of a conspiracy—a cover-up—that, according to Republicans, involved Fauci and others in the U.S. government swaying Andersen and Garry to leave behind their scientific judgment and endorse “pro-China talking points” instead. (Fauci has denied that he tried to disprove the lab-leak theory.)

    Barbed accusations of this kind have only added headaches to the question of how the pandemic really started. For all of its distractions, though, the House investigation still serves a useful purpose: It sheds light on how discussions of the lab-leak theory went so very, very wrong, and turned into an endless, stultifying spectacle. In that way, the hearing—and the story that it tells about the “Proximal Origin” paper—gestures not toward the true origin of COVID, but toward the origin of the origins debate.

    From the start, the problem has been that a “lab leak” could mean many things. The term may refer to the release of a manufactured bioweapon, or to an accident involving basic-science research; it could involve a germ with genes deliberately inserted, or one that was rapidly evolved inside a cage or in a dish, or even a virus from the wild, brought into a lab and released by accident (in unaltered form) in a city like Wuhan. Yet all these categories blurred together in the early days of the pandemic. The confusion was made plain when Senator Tom Cotton of Arkansas, a hard-core China hawk, aired a proto-lab-leak theory in a February 16, 2020 interview with Fox News. “This virus did not originate in the Wuhan animal market,” he told the network. He later continued, “just a few miles away from that food market is China’s only biosafety-level-4 super-laboratory that researches human infectious diseases. Now, we don’t have evidence that this disease originated there, but because of China’s duplicity and dishonesty from the beginning, we need to at least ask the question.”

    Cotton did not specifically suggest that the Chinese “super-laboratory” was weaponizing viruses, nor did he say that any laboratory accident would necessarily have involved a genetically engineered virus, as opposed to one that had been cultured or collected from a bat cave. Nevertheless, The New York Times and The Washington Post reported that the senator had repeated a “fringe theory” about the coronavirus that was going around in right-wing circles at the time, that it had been manufactured by the Chinese government as a bioweapon. It was hard for reporters to imagine that Cotton could have been suggesting anything but that: The idea that Chinese scientists might have been collecting wild viruses, and doing research just to understand them, was not yet thinkable in that chaotic, early moment of pandemic spread. “Lab leak” was simply understood to mean “the virus is a bioweapon.”

    Scientists knew better. On the same day that Cotton gave his interview, one of Andersen and Garry’s colleagues posted the “Proximal Origin” paper on the web as an unpublished manuscript. (“Important to get this out,” Garry wrote in an email sent to the group the following morning. He included a link to the Washington Post article about Cotton described above.) In this version, the researchers were quite precise about what, exactly, they were aiming to debunk: The authors said, specifically, that their analysis clearly showed the virus had not been genetically engineered. It might well have been produced through cell-culture experiments in a lab, they wrote, though the case for this was “questionable.” And as for the other lab-leak possibilities—that a Wuhan researcher was infected by the virus while collecting samples from a cave, or that someone brought a sample back and then accidentally released it—the paper took no position whatsoever. “We did not consider any of these scenarios,” Andersen explained in his written testimony for this week’s hearing. If a researcher had indeed been infected in the field, he continued, then he would not have counted it as a “lab leak” to begin with—because that would mean the virus jumped to humans somewhere other than a lab.

    Rather than settling the matter, however, all this careful parsing only led to more confusion. In the early days of the pandemic, and in the context of the Cotton interview and its detractors, too much specificity was deemed a fatal flaw. On February 20, Nature decided to reject the manuscript, at least partly on account of its being too soft in its debunking. A month later, when their paper finally did appear in Nature Medicine, a new sentence had been added near the end: the one discounting “any type of laboratory-based scenario.” At this crucial moment in the pandemic-origins debate, the researchers’ original, narrow claim—that SARS-CoV-2 had not been purposefully assembled—was broadened to include a blanket statement that could be read to mean the lab-leak theory was wrong in all its forms.

    Over time, this aggressive phrasing would cause problems of its own. At first, its elision of several different possible scenarios served the mainstream narrative: We know the virus wasn’t engineered; ergo, it must have started in the market. More recently, the same confusion has served the interests of the lab-leak theorists. Consider a report from the Office of the Director of National Intelligence on pandemic origins, declassified last month. American intelligence agencies have determined that SARS-CoV-2 was not developed as a bioweapon, it explains, and they are near-unanimous in saying that it was not genetically engineered. (This confirms what Andersen and colleagues said in the first version of their paper, way back in February 2020.) “Most” agencies, the report says, further judge that the virus was not created through cell-culture experiments. Yet the fact that two of the nine agencies nonetheless believe that “a laboratory-associated incident” of any kind is the most likely cause of the first human infection has been taken as a sign that all lab-leak scenarios are still on the table. Thus Republicans in Congress can rail against Facebook for removing posts about the “lab-leak theory,” while ignoring the fact that the platform’s rules only ever prohibited one particular and largely discredited idea, that SARS-CoV-2 was “man-made or manufactured.” (In any case, that prohibition was reversed some three months later.)

    Where does this leave us? The committee’s work does not reveal a cover-up of COVID’s source. At the same time, it does show that the authors of the “Proximal Origin” paper were aware of how their work might shape the public narrative. (In a Slack conversation, one of them referred to “the shit show that would happen if anyone serious accused the Chinese of even accidental release.”) At first they strived to phrase their findings as clearly as they could, and to separate the strong evidence against genetic engineering of the virus—and what Garry called “the bio weapon scenario”—from the lingering possibility that laboratory science might have been involved in some other way. In the final version of their paper, though, they added in language that was rather less precise. This may have helped to muffle the debate in early 2020, but the haze it left behind was noxious and long-lasting.

    Daniel Engber

    Source link

  • Your Phone Is a Mindfulness Trap

    Your Phone Is a Mindfulness Trap

    “Let’s travel now to moonlit valleys blanketed with heather,” Harry Styles says to me. The pop star’s voice—just shy of songful, velvet-dry—makes it seem as if we’re at a sleepaway camp for lonely grown-ups, where he is my fetching counselor, and now it’s time for lights out.

    Styles’s iambic beckoning lies within a “sleep story” in the mindfulness app Calm. Like many of its competitors, Calm has become a catchall destination for emotional well-being. In recent years, I’ve cycled through several of these platforms. Using them turns the amorphous, slightly unaccountable act of meditation into something I can accomplish, and cross off the list. That’s the forte of the modern mobile app, after all: easing the completion of a discrete task. Send an email, watch a show, order Kleenex, run at a moderate pace for 30 minutes, doomscroll yourself to sleep. There’s an app for it, and you’ll know when you’re done.

    The most popular mindfulness apps have roots in this model, outcome-oriented and timebound. Traditional meditation disciplines can be open-ended, fuzzy, and noncommittal in their benefits, which might take months or years to accrue. Plus, they are disciplines, anchored in study and practice and receiving instruction, and, quite often, traversing periods of frustration. Calm, Headspace, Insight Timer, and Ten Percent Happier all offer neat repackagings of the underlying product. Don’t have half an hour to sit around in witness of your inner being’s birthright quietude? No problem: Here’s a three-minute guided option for the bus. Maybe you’re going through a bout of insomnia and heard that a mindfulness practice could help? To put you to bed, here’s a spoken lullaby from Matthew McConaughey.

    There is obvious good in this—in anything that dials down the temperature, that provides some relief from the ever-present human thrum of animus and danger. Headspace—the thing, not the brand—is something 100 percent of us could use more of. And these have been popular years for Big Mindful. In 2022, Calm reportedly had 4 million paid subscribers. In 2021, Headspace merged into a health-care endeavor backed by Blackstone that was valued in the billions. Fox is expanding the Ten Percent Happier franchise into a TV show—a comedy. Peace of mind is a business opportunity.

    But what are the apps selling, really? Mindfulness—let’s define that tersely as the ability to be present in your sensations without judgment—is an aim compatible with a range of lifestyles and beliefs. It’s so compatible as to invite blanket application: mindful eating, mindful meetings, mindful sleeping, mindful fights. Stripping some of the negative charge from life’s tediums and hardships can benefit anybody. But the mindfulness platforms have taken each of these use cases as a jumping-off point for another tile on the screen, another video or podcast, another claim on your gaze. And here, mindfulness seems to blur into something bigger and so different as to verge on its opposite: mindfulishness.

    The first time I quit Headspace was because of an ad—for Headspace—on the subway. I don’t remember exactly what it said, but it was akin in spirit and tone to “I meditate to crush it,” part of the company’s 2016 growth campaign. This frontally transactional framing so reviled me—and so differed from my experience, which is that meditation doesn’t mimic the reliability of a Toyota—that I canceled my subscription on the spot.

    By coincidence, I’d recently started to frequent a place where phones weren’t even allowed: a yoga studio. I’m 6 foot 3, with hamstrings that could wire a tennis racket, and restless down to my organelles. But a cycling crash had sent me to physical therapy, which sowed the first seeds of flexibility and balance, along with just enough patience to make it through a simple restorative-yoga class. In the early days, I was treading a sea of thoughts and anxieties, my attention on everything but my breath and the poses. As the practice became less foreign to my body, and helped me release deeply buried tensions, I would leave with an unprecedented sense of stillness. This was more than a five- or 10-minute retreat from the buzz of life, and—even as I got into more vigorous classes—it was more than a workout: It was a complex orchestration, the body marshaling itself in support of the mind’s deliberate, repetitive self-grounding.

    If only there were always an hour for yoga. In a frenetic job leading the news desk at The New York Times, during and after the 2016 presidential race, I missed the hand’s-reach lull of Headspace—particularly the bright, lilting vibe and voice of its co-founder and front man, Andy Puddicombe, a former Buddhist monk. There’s something primally calming about a few minutes with a pleasantly timbred human, confident and chill, and Puddicombe is as adept a meditation teacher and guide as I’ve encountered. So I signed up again, and off I’d go mid-morning to a borrowed glass-door office.

    Still, I found myself more and more inclined to fidget with my phone, instead of meditate, as Puddicombe spoke. On some days, I would finish my meditation without even a single moment of interior quiet. This is a problem easily enough solved, I know: Just turn up the volume and put the phone across the room. But anyone who has ever had an hour slip away to texts knows that it’s not that simple. Your phone can be anything—including a grenade, its target the cohesion and integrity of your thoughts. For almost anyone who owns one, a smartphone is not only the most omnipresent distraction from a mindfulness practice; it’s also most likely a principal vector for much of the stuff that unfocuses, stresses, addicts, enrages, or dismays you. Just having your phone in the room—it can be in your pocket, turned off—has been found to meaningfully diminish cognitive capacity. Using it to meditate, I started to realize, is like learning you have high cholesterol and signing up for a subscription to bacon.

    The most productive move for any mindfulness app would be to engineer ways for you to spend as little time interacting with your phone as possible, as you focus on centering your awareness. But most of the big meditation apps have something less obvious in common than their nominal purpose: They’re subscription-driven content machines whose existence depends on you consuming the content. Open one up and you’re likely to see a whole day of programming laid out for you. In Headspace, for example, you can start with a few deep, animation-assisted breaths, then watch a moody video about an in-the-zone English bookbinder, before you even get to the day’s main meditation, with a choice of two English-language guides or a German one. When the 3 o’clock doldrums hit, slide into “Your Afternoon Lift,” a video of nature scenes: whales frolicking, jellyfish jellying. And nod off later to a sleepcast, or switch apps and return to Harry Styles’s moonlit valleys.

    I spoke with representatives of Calm and Headspace for this story, and both emphasized to me the ways their apps could be used without actively looking at a screen. They also defended the value of the access that phones provide: meditation anywhere, anytime, for people who might otherwise lack exposure to mindfulness techniques. Under this view, the omnipresence of phones is a blessing. “We would have folks who would download the app in the parking lot of the hospital while their mom is in surgery to have this kind of anchor point of support,” Cal Thompson, who runs design at Headspace, told me. “Some people have great friends they can call, some people have a great teacher on speed dial, but really, not everyone can have that.” As Thompson spoke, I thought of those days back at the Times, when a few minutes with Andy Puddicombe were the only port in a storm.

    Thompson didn’t buy my argument about phones being too much of an intrinsic distraction. “I think that’s the dynamic that a lot of us have created with our phones, that we’ve set it up in such a way where it can consume our attention,” Thompson, who uses they/them pronouns, said. “And what we actually need to own and change is that behavior.” Attaching mindfulness practices to more parts of our day, they contended, helps us “get more clear about what we are doing in our lives and make more mindful choices. And then, from that place, it makes it a lot easier for us to use or not use our phones.”

    This way of looking at things resonated with me, to a degree, as I listened back to my recording of our conversation. Then it took me three tries to transcribe Thompson’s quote. First my boyfriend texted me about the grocery list. Then someone needed my Venmo name to sell me some tickets. Then I looked up and realized I was in the kitchen for another round of peanut-butter pretzels. I might be generalizing too much based on my own attentional inadequacy, but lots of people I know use their phone more than they want to. If it’s not a universal affliction, it’s common. In my own case, meditating has not solved that problem, but moving meditation away from my phone has made it more of a refuge.

    The word mindfulness is an accurate label insofar as it describes paying attention to the content of our mind. But it misleads, as I found in yoga, in its omission of our body. The path to thinking and feeling from hormones and nerves is in some sense linear, often traceable. And the physical state of the organism—pained, eager, bracing, soft—tracks with the text and nature of our thoughts. A professor of mine once referred to bodies as “brain buckets,” an image that anyone who’s gone through the physical deprivations of finals week can relate to. Most phone apps have their business with the brain, not the bucket. But my professor was joking: Everything we are comes from the whole big blob.

    A phone is not a villain, just a vessel. But with some narrow exceptions, where movement is the point, it does tend to exert on us a kind of physical binding, an arrest of motion and focus. Some of the apps I’ve mentioned include a daily yoga video or cues for a mindful run, but these serve a double purpose, roping our assertions of embodiment back into the hungry domain of the screen. Do you know what else is on that screen? Instagram. The effect of a mindfulness app, as with any other kind, is to keep you in the place you already spend much of your time. It’s a motionless place, and, not by coincidence, also a bit mindless.

    Michael Owen

    Source link

  • Nikki Haley’s Dilemma Is Also the Republicans’ Problem

    Nikki Haley’s Dilemma Is Also the Republicans’ Problem

    Republicans have had 10 months to hammer out a coherent post-Roe message on abortion. You would think they’d have nailed it by now.

    Yet on Tuesday, Nikki Haley set out to declare her position on the issue—and proceeded to be about as clear as concrete.

    She began with plausible precision. “I want to save as many lives and help as many moms as possible,” the former South Carolina governor and ambassador to the United Nations told reporters gathered at the Susan B. Anthony Pro-Life America headquarters, in Northern Virginia—a press event billed as a “major policy speech.” But her statements quickly got squishier. It’s good that some states have passed anti-abortion laws in the past year, she said. And as for the states that have reacted by enshrining abortion-rights protections? Well, she wishes “that weren’t the case.”

    And then she seemed to channel Veep’s Selina Meyer. “Different people in different places are taking different paths,” Haley said, with a self-assurance that belied the indeterminacy of her words.

    Questioning whether any national anti-abortion legislation would ever pass, Haley did gesture at a need for some action. “To do that at the federal level, the next president must find national consensus,” she said. As for what that might look like, she had no words. And she took no questions.

    Some people seemed to like Haley’s speech, in a tepid way. She sounded human when she described how her husband had been adopted, and how she’d struggled with infertility. “Ms. Haley deserves credit for confronting the subject head on, with a speech that wasn’t sanctimonious or censorious,” The Wall Street Journal’s editorial board wrote, before concluding, “The party could do worse than Ms. Haley’s pitch.” But it could do better—or at least do with something more specific.

    Leaders of the self-described pro-life movement were predictably annoyed at Haley’s conciliatory-sounding vagueness. “Disappointing speech by @NikkiHaley today. Leads with compromise & defeatism, not vision & courage,” Lila Rose, who heads the group Live Action, tweeted. “We agree that consensus is important, but to achieve consensus we will need to stake out a principled position,” wrote Kristan Hawkins, the president of Students for Life of America.

    Even Haley’s hosts seemed on the wrong page. “We are clear on Ambassador Haley’s commitment to acting on the American consensus against late-term abortion by protecting unborn children by at least 15 weeks,” Marjorie Dannenfelser, the president of Susan B. Anthony Pro-Life America, said in a statement sent to me. But a few hours later, Team Haley emailed me to correct the record: “She committed to working to find a consensus on banning late-term abortion. No specific weeks,” Nachama Soloveichik, Haley’s communications director, wrote. Not only did Haley alienate both sides—she confused them!

    Haley is in a tough spot, as are all of the Republican presidential wannabes. They each have their own personal convictions on abortion; former Vice President Mike Pence, for example, has been outspoken in his support for a national ban. But they’re up against an issue that seems to have cost their party a string of recent elections. Most Americans believe that abortion should be accessible, with some limits.

    The “consensus” position, then, is somewhere in the foggy zone between no abortion ever and abortion whenever. But primary elections tend to push candidates toward one extreme or another. “The gap between what the base demands and what swing voters will tolerate has gotten really wide,” Sarah Longwell, the publisher of the Never Trump site The Bulwark, told me. “Nowhere is this more true than on abortion.”

    What all politicians need to do “is settle on a position they believe they can defend, and they need to repeat it consistently and clearly,” Whit Ayres, a Republican strategist, told me. “Any politician whose position on abortion is vague will be wrapped around the axle eventually with questions and doubts about where they actually stand.”

    Some GOP candidates have followed Ayres’s advice. But much axle-wrapping has occurred already in the early days of the 2024 primary season.

    Asked on the campaign trail whether he’d support a 15-week federal ban on abortion, Senator Tim Scott of South Carolina told CBS, “I do believe that we should have a robust conversation about what’s happening on a very important topic,” before pivoting so hard to an anecdote about Janet Yellen that I thought he’d need a neck brace. In a follow-up interview, Scott backtracked, clarifying that as president, he would “literally sign the most conservative pro-life legislation” Congress sent to his desk.

    Florida Governor Ron DeSantis, who is expected to mount a presidential bid, did approve a very conservative state law recently—a six-week abortion ban. But he signed that legislation in the dead of night earlier this month, while most people in Tallahassee were probably in bed. (By contrast, last year, he celebrated the signing of a 15-week ban with a big party at a church.) The following day, DeSantis gave a speech at a Christian university full of students who are opposed to abortion, yet said nothing about his major legislative achievement. He’s mostly stayed quiet about it since—even at glad-handing events in early primary states.

    So far, the only confirmed presidential candidate who seems clear on his position and keenly aware of the political optics is Donald Trump. Despite being hailed by anti-abortion activists as the “most pro-life president” in history, Trump has never been rigid on abortion (probably because he supported abortion rights for most of his life as a public figure), and he doesn’t talk much about the issue now. But a spokesperson told The Washington Post recently that Trump “believes that the Supreme Court, led by the three Justices which he supported, got it right when they ruled this is an issue that should be decided at the State level.” Shorter Trump: I’ve done my bit—it’s up to the states now. God bless.

    If any national consensus on abortion exists, the GOP strategist Ayres said, Trump’s position “is pretty close” to it. Trump has always seemed to have “a lizard-brain sense of where the voters are,” Longwell said. “He has a relationship to the base, and he doesn’t have to pitch what he believes.” And, unlike DeSantis, Trump has never signed a law banning abortion at any stage, so it’ll be harder to pin him down. Sure, there’s an activist class that would like to see abortion banned in all cases. To them, Trump could reply, You got your justices. You’re welcome.

    Right now Trump and his lizard brain have a commanding lead in the GOP primary. His victory would set up an interesting general-election situation—a fitting one for our complicated post-Roe country: a former president who once personally supported abortion rights and is now politically opposed to them running against a sitting president whose own position on abortion is the exact opposite.

    Until a Republican presidential nominee emerges, we’ll hear many more Haley-esque platitudes that sound thoughtful and weighty but ultimately aren’t.

    “Whether we can save more lives nationally depends entirely on doing what no one has done to date,” Haley told reporters on Tuesday, before wrapping up her speech with—you could almost hear a drumroll—“finding consensus.” The waffling will continue, in other words, until the primary concludes.

    Elaine Godfrey

    Source link

  • A Radical Idea to Split Parenting Equally

    A Radical Idea to Split Parenting Equally

    While her wife was pregnant with their son, Aimee MacDonald took an unusual step of preparing her own body for the baby’s arrival. First she began taking hormones, and then for six weeks straight, she pumped her breasts day and night every two to three hours. This process tricked her body into a pregnant and then postpartum state so she could make breast milk. By the time the couple’s son arrived, she was pumping 27 ounces a day—enough to feed a baby—all without actually getting pregnant or giving birth.

    And so, after a 38-hour labor and emergency C-section, MacDonald’s wife could do what many mothers who just gave birth might desperately want to but cannot: rest, sleep, and recover from surgery. Meanwhile, MacDonald tried nursing their baby. She held him to her breast, and he latched right away. Over the next 15 months, the two mothers co-nursed their son, switching back and forth, trading feedings in the middle of the night. MacDonald had breastfed her older daughter the usual way—as in, by herself—a decade earlier, and she remembered the bone-deep exhaustion. She did not want that for her wife. Inducing lactation meant they could share in the ups and the downs of breastfeeding together.

    MacDonald, who lives in a small town in Nova Scotia, had never met anyone who had tried this before. People she told were routinely shocked to learn that induced lactation—making milk without pregnancy—is biologically possible. They had so many questions: Was it safe? Did she have side effects? How did it even work? But when she described how she and her wife shared nursing duties, many women told her, “I wish I had had that.”

    Induced lactation wasn’t initially developed for co-nursing. Mothers who wanted to breastfeed their adoptive babies were the first to experiment with hormones and pumping. But over time, the few experts who specialize in induced lactation told me, that has given way to more queer couples who want to share or swap nursing duties. Early in her career, Alyssa Schnell, a lactation consultant in St. Louis who herself breastfed her adopted daughter 17 years ago, found that when she suggested to same-sex couples that the non-birthing partner might try nursing, “they would be horrified.” The idea that a woman would nurse a baby she did not give birth to—common in the era of wet nurses—had become strange in our era of off-the-shelf formula. Now parents are coming to her asking to induce lactation, and more of them are interested in co-nursing.

    About a quarter of all babies in the U.S. are breastfed exclusively for six months; more than half are breastfed at least some of the time. The statistics don’t say by whom, but that’s because they don’t need to. We can assume it’s virtually always their birthing mother. Even with the help of formula, the pressure around or preference for breastfeeding means that, in many families, the work of feeding falls disproportionately on one parent. But induced lactation decouples breastfeeding from birth. By manipulating biology, parents who co-nurse are testing the limits of just how equal a relationship can truly be.


    Breastfeeding is hard work, even when it’s “natural.” Adding induced lactation is harder work still. MacDonald was putting herself on a newborn schedule weeks before her baby was even born. She pumped at home. She pumped at work. She even pumped while her wife was in labor, because skipping sessions can cause milk supply to drop. As Diane Spatz, a lactation expert at the University of Pennsylvania and Children’s Hospital of Philadelphia, puts it, “You have to start pumping like a wild person.”

    MacDonald followed a version of the Newman-Goldfarb protocol, named after a pediatrician and an adoptive mother who documented and shared the process in 2000. In addition to pumping, the protocol includes birth control, which causes a surge of progesterone and estrogen akin to pregnancy hormones, and a drug called domperidone, which boosts the milk hormone prolactin. Together they biochemically prime the body for milk production. It’s unusual, Schnell told me, for a woman inducing lactation to make enough milk to feed a baby all on her own—unless she’s breastfed before, like MacDonald had—but it’s also unusual to make no milk at all.

    In the U.S., getting domperidone can be a challenge. Though the drug is widely available in Canada, Australia, and Europe, the FDA has banned it in the United States, citing the risk of abnormal heart rhythms and even death. But these heart problems have shown up only in the elderly, foreign experts have noted, and Australian scientists concluded in a 2019 review that domperidone is safe for lactation, as long as women are screened for heart conditions. But in the U.S., parents usually aren’t taking it under the supervision of a doctor. They might buy pills with a prescription at a Canadian pharmacy or surreptitiously order the drug online through overseas pharmacies. “There was a brief moment when you could only buy it in Bitcoin,” says Lauren Vallone, whose partner, Robin Berryman, induced lactation so that they could co-nurse their daughter, who was born in 2020.

    Inducing lactation felt like a DIY project to Vallone and Berryman. As a queer couple trying to start a family, though, they were also used to doing things a different way. They eventually reached out to Schnell for guidance, but they also swapped tips in a Facebook support group that had a wealth of anecdotal advice. Not that most doctors would have been helpful. Even the idea that one can breastfeed without having been pregnant isn’t widely known, Spatz told me. “Nurses are surprised about that,” she said. “Physicians don’t know that.”

    Vallone and Berryman planned to divide nursing duties 50/50, but they didn’t know exactly what that would look like. Would they trade off every other feeding? Would one nurse while the other pumped? What about when one parent went back to work? “There’s stories of people who have induced lactation, but then there’s no, like, ‘Well, what does your day look like?’” Vallone told me. They had no script to follow, so they could write their own. They envisioned giving themselves equal roles from the start, much like how many same-sex couples share a more equal division of labor, because they do not come in with the gender baggage of a heterosexual relationship.

    What Vallone and Berryman did not want was to lapse into the roles that they watched their friends fall into, where the birthing parent becomes the breastfeeding parent becomes the default parent. The arrival of a new baby is a delicate time in any relationship—for many reasons, but in no small part because it disrupts whatever division of labor was previously agreed upon. Here is a tiny helpless human, along with a mountain of new tasks necessary to keep them alive. If the baby is breastfed, now a large share of that labor can be done by only one parent. In her case against breastfeeding in The Atlantic in 2009, Hanna Rosin described how that initial inequality persists and festers over the years: “She alone fed the child, so she naturally knows better how to comfort the child, so she is the better judge to pick a school for the child and the better nurse when the child is sick, and so on.” But what if—under very specific circumstances at least—breastfeeding did not fall solely on one parent? What if instead of parenthood starting off on unequal footing, it could be perfectly equal from the very beginning?


    For a while, Vallone and Berryman did trade off feedings, and both continued to pump, because they worried that their milk supplies would drop. They tracked every ounce in a shared spreadsheet. (This careful data logging actually allowed Schnell to write a case study about the couple.) The pumping eventually became too much—they couldn’t sleep if they were pumping!—but they have kept co-nursing for two years now.

    From the early days, they saw that nursing not only nourished their baby but also soothed her when she cried, made her sleepy when she was tired but fussy. So the work of not just feeding but all-round caregiving fell on them more equally. In the morning, they could alternate one person waking up early with the baby, the other sleeping in. At night, one parent could go out with friends without racing home for bedtime or pumping a bottle of breast milk for the other to feed. Because they could each provide everything their baby wanted, they were also each freer. Breastfeeding simultaneously deepened their relationships with their baby and allowed them a life outside of that. “You really get a sense of how radical it is to have caretaking split so evenly,” Vallone said. The couple is now trying for their second child, which Berryman plans to carry. They plan to co-nurse again.

    Vallone and Berryman did, however, run into an unexpected obstacle to their co-nursing: their baby. She at one point refused to nurse on Vallone, the birthing parent, and wanted to nurse only on Berryman. Any parent is probably familiar with how babies can develop seemingly arbitrary preferences: breast over bottle, left breast over right breast, even. As they get older, toddlers, too, go through periods of wanting only one parent or another to feed, clothe, bathe, or comfort them. In this case—as in many cases—Vallone and Berryman had to be deliberate about returning to a more even state. At its most intense, Berryman would sleep away from the baby in another room; it got better over time, but it also sometimes got worse. Equality did not come easily even with two nursing parents, which perhaps isn’t surprising. The advent of formula did not magically render all marriages equal. Vallone and Berryman still had to work toward keeping their co-nursing relationship as balanced as possible. Dividing work is also, well, work.

    Not all couples who induce lactation end up splitting breastfeeding evenly. Some are not able to, and some don’t even want to. For example, one parent might choose to carry the baby while the other takes on breastfeeding. Some of the women I spoke with were primarily motivated to induce lactation to pass along their antibodies in breast milk, or to physically bond with a baby they did not carry. Even for those who never made more than a few of the roughly 25 ounces a baby typically needs every day, being able to comfort nurse—when a baby sucks more for soothing than for nourishment—was meaningful. They could nurse their baby to sleep or calm them when upset. It brought the parents closer together too: Although inducing lactation is not equivalent to pregnancy, both parents felt like their bodies were preparing for a baby together. And later, they could troubleshoot a bad latch or clogged duct together. Breastfeeding can be an isolating experience when one parent is attached to a baby eight times a day and the other looks on a bit helplessly; co-nursing made it less so.

    Because induced lactation has flown under the radar of mainstream science for so long, a lot remains unknown. A couple of small studies suggest that the protein and sugar content of induced breast milk is in the normal range, but detailed experiments into, for example, the mix of antibodies have never been done. And why are some women inducing lactation able to produce more than others? Schnell has noticed that those who have struggled with infertility or hormonal balances usually make less milk. She has worked with trans women, too, who are able to make milk, though usually not in large amounts. Men, theoretically, could lactate as well; early studies into domperidone actually noted this as a side effect. There are anecdotal reports of men breastfeeding infants, but there’s virtually no research into the phenomenon.

    One mother I interviewed, Morgan Lage, told me that her experience inducing lactation to breastfeed her daughter inspired her to train as a lactation consultant, and she hopes now to fill in some of the many unknowns. The Newman-Goldfarb protocol is widely used as the template for anyone attempting induced lactation, but no one has rigorously studied the optimal time to initiate pumping or birth control. Lage started pumping earlier than the protocol suggested, and she wonders if that’s why she was able to have a full milk supply despite never having breastfed before. She loved nursing her daughter. She loved feeling “just as important and needed” in the fleeting, precious period of infancy.

    I know what Lage means about feeling needed, though perhaps because I breastfed solo—as most mothers do—I did not always love it. Still, I remember staring at my baby’s eyelashes and toes, marveling at how nearly every molecule in her body came from mine. We did supplement with formula, too, in part because we wanted my husband to be involved in her feeding. Although the bottle satisfied her hunger, it did not always satisfy some primal need for comfort. During her most inconsolable nights, my husband would spend hours trying to soothe her with every trick in the book, only for her to fall quiet and asleep the minute I nursed her. This frustrated us both. To be needed this way was a burden and a joy. I was sorry, for both of us, that we could not share it.

    Sarah Zhang

    Source link

  • Donald Trump Is on the Wrong Side of the Religious Right

    Donald Trump Is on the Wrong Side of the Religious Right

    The sanctuary buzzed as Mike Pence climbed into the elevated pulpit, standing 15 feet above the pews, a Celtic cross over his left shoulder. The former vice president had spoken here, at Hillsdale College, the private Christian school tucked into the knolls of southern Michigan, on several previous occasions. But this was his first time inside Christ Chapel, the magnificent, recently erected campus cathedral inspired by the St. Martin-in-the-Fields parish of England. The space offers a spiritual refuge for young people trying to find their way in the world. On this day in early March, however, it was a political proving ground, a place of testing for an older man who knows what he believes but, like the students, is unsure of exactly where he’s headed.

    “I came today to Christ Chapel simply to tell all of you that, even when it doesn’t look like it, be confident that God is still working,” Pence told the Hillsdale audience. “In your life, and in mine, and in the life of this nation.”

    It only stands to reason that a man who felt God’s hand on his selection to serve alongside Donald Trump—the Lord working in mysterious ways and all—now feels called to help America heal from Trump’s presidency. It’s why Pence titled his memoir, which describes his split with Trump over the January 6 insurrection, So Help Me God. It’s why, as he travels the country preparing a presidential bid, he speaks to themes of redemption and reconciliation. It’s why he has spent the early days of the invisible primary courting evangelical Christian activists. And it’s why, for one of the first major speeches of his unofficial 2024 campaign, he came to Hillsdale, offering repeated references to scripture while speaking about the role of religion in public life.

    Piety aside, raw political calculation was at work. Trump’s relationship with the evangelical movement—once seemingly shatterproof, then shaky after his violent departure from the White House—is now in pieces, thanks to his social-media tirade last fall blaming pro-lifers for the Republicans’ lackluster midterm performance. Because of his intimate, longtime ties to the religious right, Pence understands the extent of the damage. He is close personal friends with the organizational leaders who have fumed about it; he knows that the former president has refused to make any sort of peace offering to the anti-abortion community and is now effectively estranged from its most influential leaders.

    According to people who have spoken with Pence, he believes that this erosion of support among evangelicals represents Trump’s greatest vulnerability in the upcoming primary—and his own greatest opportunity to make a play for the GOP nomination.

    But he isn’t the only one.

    Although Pence possesses singular insights into the insular world of social-conservative politics, numerous other Republicans are aware of Trump’s emerging weakness and are preparing to make a play for conservative Christian voters. Some of these efforts will be more sincere—more rooted in a shared belief system—than others. What unites them is a common recognition that, for the first time since he secured the GOP nomination in 2016, Trump has a serious problem with a crucial bloc of his coalition.

    The scale of his trouble is difficult to overstate. In my recent conversations with some two dozen evangelical leaders—many of whom asked not to be named, all of whom backed Trump in 2016, throughout his presidency, and again in 2020—not a single one would commit to supporting him in the 2024 Republican primary. And this was all before the speculation of his potential arrest on charges related to paying hush-money to his porn-star paramour back in 2016.

    “I think people want to move on. They want to look to the future; they want someone to cast a vision,” said Tony Perkins, the president of the Family Research Council, who spoke at Trump’s nominating convention in 2016 and offered counsel throughout his presidency.

    At this time eight years ago, Perkins was heading up a secretive operation that sought to rally evangelical support around a single candidate. One by one, all the GOP presidential aspirants met privately with Perkins and his group of Christian influencers for an audition, a process by which Trump made initial contact with some prominent leaders of the religious right. Perkins probably won’t lead a similar effort this time around—“It was a lot of work,” he told me—but he and his allies have begun meeting with Republican contenders to gauge the direction of their campaigns. His message has been simple: Some of Trump’s most reliable supporters are now up for grabs, but they won’t be won over with the half measures of the pre-Trump era.

    “Oddly enough, it was Donald Trump of all people who raised the expectations of evangelical voters. They know they can win now,” Perkins said. “They want that same level of fight.”

    It’s one of the defining political statistics of the current political era: Trump carried 81 percent of the white evangelical vote in 2016, according to exit polling, and performed similarly in 2020. But the real measure of his grip on this demographic was seen during his four years in office: Even amid dramatic dips in his popularity and approval rating, white evangelicals were consistently Trump’s most loyal supporters, sticking by him at rates that far exceeded those of other parts of his political coalition. Because Trump secured signature victories for conservative Christians—most notably, appointing the three Supreme Court justices who, last year, helped overturn Roe v. Wade—there was reason to expect that loyalty to carry over into his run for the presidency in 2024.

    And then Trump sabotaged himself. Desperate to dodge culpability for the Republican Party’s poor performance in the November midterm elections, Trump blamed the “abortion issue.” He suggested that moderate voters had been spooked by some of the party’s restrictive proposals, while pro-lifers, after half a century of intense political engagement, had grown complacent following the Dobbs ruling. This scapegoating didn’t go over well with social-conservative leaders. For many of them, the transaction they had entered into with Trump in 2016—their support in exchange for his policies—was validated by the fall of Roe. Yet now the former president was distancing himself from the anti-abortion movement while refusing to accept responsibility for promoting bad candidates who lost winnable races. (Trump’s campaign declined to comment for this story.)

    It felt like betrayal. Trump’s evangelical allies had stood dutifully behind him for four years, excusing all manner of transgressions and refusing countless opportunities to cast him off. Some had even convinced themselves that he had become a believer—if not an actual believer in Christ, despite those prayer-circle photo ops in the Oval Office, then a believer in the anti-abortion cause after previously having described himself as “very pro-choice.” Now the illusion was gone. In text messages, emails, and conference calls, some of the country’s most active social conservatives began expressing a willingness to support an alternative to Trump in 2024.

    “A lot of people were very put off by those comments … It made people wonder if in some way he’d gone back to some of the sentiments he had long before becoming a Republican candidate,” said Scott Walker, the former Wisconsin governor, who runs the Young America’s Foundation and sits on the board of an anti-abortion group. Walker, himself an evangelical and the son of a pastor, added, “I think it opened the door for a lot of them to consider other candidates.”

    The most offensive part of Trump’s commentary was his ignorance of the new, post-Roe reality of Republican politics. Publicly and privately, he spoke of abortion like an item struck from his to-do list, believing the issue was effectively resolved by the Supreme Court’s ruling. Meanwhile, conservatives were preparing for a new and complicated phase of the fight, and Trump was nowhere to be found. He didn’t even bother with damage control following his November outburst, anti-abortion leaders said, because he didn’t understand how fundamentally out of step he was with his erstwhile allies.

    “He thinks it will go away, but it won’t,” Marjorie Dannenfelser, the president of the Susan B. Anthony List, an anti-abortion group, told me. “That’s not me lacking in gratitude for how we got here, because I know how we got here. But that part is done. Thank you. Now what?”

    Before long, evangelical leaders were publicly airing their long-held private complaints about Trump. Mike Evans, an original member of Trump’s evangelical advisory board, told The Washington Post that Trump “used us to win the White House” and then turned Christians into cult members “glorifying Donald Trump like he was an idol.” David Lane, a veteran evangelical organizer whose email blasts reach many thousands of pastors and church leaders, wrote that Trump’s “vision of making America as a nation great again has been put on the sidelines, while the mission and the message are now subordinate to personal grievances and self-importance.” Addressing a group of Christian lawmakers after the election, James Robison, a well-known televangelist who also advised Trump, compared him to a “little elementary schoolchild.” Everett Piper, the former president of Oklahoma Wesleyan University, reacted to the midterms by writing in The Washington Times, “The take-home of this past week is simple: Donald Trump has to go. If he’s our nominee in 2024, we will get destroyed.”

    Perkins said that he’s still in touch with Trump and wouldn’t rule out backing his primary campaign in 2024. (Like everyone else I spoke with, Perkins said he won’t hesitate to support Trump if he wins the nomination.) He’s also a longtime friend to Pence, and told me he has been in recent communication with the former vice president. In speaking of the two men, Perkins described the same dilemma I heard from other social-conservative leaders.

    “Donald Trump came onto the playground, found the bully that had been pushing evangelicals around, and he punched them. That’s what endeared us to him,” Perkins explained. “But the challenge is, he went a little too far. He had too much of an edge … What we’re looking for, quite frankly, is a cross between Mike Pence and Donald Trump.”

    Who fits that description? Former Secretary of State Mike Pompeo has been blasting out scripture-laden fundraising emails while aggressively courting evangelical leaders, making the case that his competence—and proud, publicly declared Christian beliefs—would make him the ultimate advocate for the religious right. Tim Scott, who has daydreamed about quitting the U.S. Senate to attend seminary, built the soft launch of his campaign around a “Faith in America” tour and is speaking to hundreds of pastors this week on a private “National Faith Briefing” call. Nikki Haley, the former South Carolina governor and U.S. ambassador to the United Nations who is known less for her devoutness than her opportunism, invited the televangelist John Hagee to deliver the invocation at her campaign announcement last month.

    Trump’s campaign is banking on these candidates, plus Pence, fragmenting the hard-core evangelical vote in the Iowa caucuses, while he cleans up with the rest of the conservative base.

    There is another Republican who could crash that scenario. And yet, that candidate—the one who might best embody the mix that Perkins spoke of—is the one making the least effort to court evangelicals.

    In January, at the National Pro-Life Summit in Washington, D.C., Florida Governor Ron DeSantis won a 2024 presidential straw poll in dominant fashion: 54 percent to Trump’s 19 percent, with every other Republican stuck in single digits. This seemed to portend a new day in the conservative movement: Having had several months to process the midterm results, the thousands of activists who came to D.C. for the annual March for Life were clearly signaling not just their desire to move on from Trump, but also their preference for the young governor who had just won reelection by 1.5 million votes in the country’s biggest battleground state.

    There was some surprise in early March when the group Students for Life of America—which had organized the D.C. conference in January—met in Naples, Florida, for its Post-Roe Generation Gala. The event drew activists from around the country. Pence, a longtime friend of the group, had secured the keynote speaking slot. But DeSantis was nowhere to be found. Some attendees wondered why there was no video sent by his staff, no footprint from his political operation, not even a tweet from the governor acknowledging the event in his own backyard.

    Kristan Hawkins, the Students for Life president, cautioned against reading anything into this, explaining that her group had not formally invited DeSantis, instead reserving the spotlight for Pence. At the same time, she complained that DeSantis has had zero engagement with her or her organization, “not even a back-channel relationship.” For all of DeSantis’s culture warring with the left—over education and wokeism and drag shows—Hawkins argued that he has largely ignored the abortion issue.

    “So many people are astounded when I tell them that Florida has one of the highest abortion rates in the country. It’s the only Republican-controlled state in the top 10,” Hawkins told me. “Folks on social media are like, ‘You’re wrong! Florida has DeSantis!’”

    She sighed. “Checking the box, yes. When asked, he’ll affirm ‘pro-life.’ But leading the charge in Tallahassee? We haven’t seen it.”

    This squared with what I’ve heard from many other evangelical leaders—in terms of both the policy approach and the personal dealings. “He doesn’t have any relationships with me or the people in my world,” Perkins told me. “I’ve been cheering for him … but he hasn’t made any real outreach to us. That’s a weakness. I guess he sort of keeps his own counsel.” Dannenfelser was the lone organizational head who told me she’d gotten some recent face time with DeSantis, while noting that she, not the governor or his team, had requested the meeting.

    DeSantis has been made aware of these complaints, according to people who have spoken with the governor. (His political team declined to comment for this story.) John Stemberger, the president of Florida Family Policy Council, told me that DeSantis had recently attended a prayer breakfast held by the state’s leading anti-abortion activists, and that his team has “slowly but methodically” begun its outreach to leaders in early-nominating states. However sluggish his efforts to date, DeSantis now stands to benefit from the good fortune of great timing: Having signed a 15-week abortion ban into law just last year, he is now supporting a so-called heartbeat bill that Republicans are advancing through the state legislature. The timing of Florida’s implementation of this new law, which would ban abortions after six weeks, will roughly coincide with the governor’s expected presidential launch later this spring.

    “He’s got a robust agenda, and he’ll be doing robust outreach soon enough,” Stemberger said.

    Even without the outreach, DeSantis is well positioned to capture a significant share of the Christian conservative vote. Among pastors and congregants I’ve met around the country, his name-identification has soared over the past year and a half, the result of high-profile policy fights and his landslide reelection win. Last month, a Monmouth University national survey of Republican voters found DeSantis beating Trump, 51 percent to 44 percent, among self-identified evangelical voters. (Trump reclaimed the lead in a new poll released this week.) This, perhaps more than any other factor, explains the intense interest in the Florida governor among conservative leaders: Unlike Pence, Haley, Pompeo, and others, DeSantis has an obvious path to defeating Trump in the GOP primary.

    Stemberger, an outspoken Trump critic during the 2016 primary who then became an apologist during his presidency—telling fellow Christians that Trump had accomplished “unprecedentedly good things” in office—would not yet publicly commit to backing DeSantis. But he suggested that the abortion issue crystallizes an essential difference between the two men: Whereas Trump “self-destructs” by “shooting from the hip all the time,” DeSantis is disciplined, deliberate, and “highly strategic.” Part of that strategy is a speech DeSantis is scheduled to deliver next month at Liberty University.

    Tellingly, Stemberger didn’t note any difference in the personal beliefs of the two Republican front-runners. I asked him: Does faith inform DeSantis’s politics?

    “It’s interesting. I know he’s Catholic, but I’m not even sure he attends Mass regularly,” Stemberger told me. He mentioned praying over DeSantis with a group of pastors before the governor’s inauguration. “But his core is really the Constitution—the Federalist Papers, the Founding Fathers. That’s how he processes everything. He’s never going to be painted as a fundamentalist Christian … He does make references to spiritual warfare, but that’s an analogy for what he’s trying to do politically.”

    Indeed, over the past year, while traveling the country to raise money and rally the conservative base, the governor frequently invoked the Book of Ephesians. “Put on the full armor of God,” DeSantis would say, “and take a stand against the left’s schemes.”

    In bowdlerizing the words of the apostle Paul—substituting the left for the devil—DeSantis wasn’t merely counting on the biblical illiteracy of his listeners. He was playing to a partisan fervor that renders scriptural restraint irrelevant. Eventually, he did away with any nuance. Last fall, DeSantis released a now-famous advertisement, cinematic frames shot in black and white, that borrowed from the radio host Paul Harvey’s famous speech, “So God Made a Farmer.” Once again, an important change was made. “On the eighth day,” rumbled a deep voice, with DeSantis pictured standing tall before an American flag, “God looked down on his planned paradise and said: ‘I need a protector.’ So God made a fighter.”

    The video, which ran nearly two minutes, was so comically overdone—widely panned for its rampant self-glorification—that its appeal went unappreciated. Trump proved that for millions of white evangelicals who fear the loss of power, influence, and status in a rapidly secularizing nation, nothing sells like garish displays of God-ordained machismo. The humble, country-preacher appeal of former Arkansas Governor Mike Huckabee has lost its political allure. Hence the irony: DeSantis might have done the least to cultivate relationships in the evangelical movement, and the most to project himself as its next champion.

    Speaking to the students at Hillsdale, Pence took a decidedly different approach to quoting the apostle Paul.

    Having spoken broadly of the need for all Americans to return to treating one another with “civility and respect,” the former vice president made a specific appeal to his fellow Christians. No matter how pitched the battles over politics and policy, he said, followers of Jesus had a responsibility to attract outsiders with their conduct and their language. “Let your conversation be seasoned with salt,” Pence said, borrowing from Paul’s letter to the Colossians.

    If he does run for president, this will be what Pence is selling to evangelicals: humility instead of hubris, decency instead of denigration. The former vice president pledged to defend traditional Judeo-Christian values—even suggesting that he would re-litigate the fight over same-sex marriage, a matter settled by courts of law and public opinion. But, Pence said, unlike certain other Republicans, he would do so with a graciousness that kept the country intact. This, he reminded the audience, had always been his calling card. As far back as his days in conservative talk radio, Pence said, he was known as “Rush Limbaugh on decaf.”

    That line got some laughs. But it also underscored his limitation as a prospective candidate. After the event, while speaking with numerous guests, I heard the same thing over and over: Pence was not tough enough. They all admired him. They all thought he was an honorable man and a model Christian. But a Sunday School teacher couldn’t lead them into the battles over gender identity, school curriculum, abortion, and the like. They needed a warrior.

    “The Bushes were nice. Mitt Romney was nice. Where did that get us?” said Jerry Byrd, a churchgoing attorney who’d driven from the Detroit suburbs to hear Pence speak. “Trump is the only one who stood up for us. The Democrats are ruining this country, and being a good Christian isn’t going to stop them. Honestly, I don’t want someone ‘on decaf.’ We need the real thing.”

    After Pence sacrificed so much of himself to stand loyally behind Trump, this is how the former president has repaid him—by conditioning Christians to expect an expression of their faith so pugilistic that Pence could not hope to pass muster.

    Byrd told me he was “done with Trump” after the ex-president’s sore-loser antics and is actively shopping for another Republican to support in 2024. He likes the former vice president. He respects the principled stand he took on January 6. But Byrd said he couldn’t imagine voting for him for president. Pence was just another one of those “nice guys” whom the Democrats would walk all over.

    Unprompted, Byrd told me that DeSantis was his top choice. I asked him why.

    “He fights,” Byrd replied.

    Tim Alberta

    Source link

  • A Major Clue to COVID’s Origins Is Just Out of Reach

    A Major Clue to COVID’s Origins Is Just Out of Reach

    Updated at 2:45 p.m. on March 21, 2023

    Last week, the ongoing debate about COVID-19’s origins acquired a new plot twist. A French evolutionary biologist stumbled across a trove of genetic sequences extracted from swabs collected from surfaces at a wet market in Wuhan, China, shortly after the pandemic began; she and an international team of colleagues downloaded the data in hopes of understanding who—or what—might have ferried the virus into the venue. What they found, as The Atlantic first reported on Thursday, bolsters the case for the pandemic having purely natural roots: The genetic data suggest that live mammals illegally for sale at the Huanan Seafood Wholesale Market—among them, raccoon dogs, a foxlike species known to be susceptible to the virus—may have been carrying the coronavirus at the end of 2019.

    But what might otherwise have been a straightforward story on new evidence has rapidly morphed into a mystery centered on the origins debate’s data gaps. Within a day or so of nabbing the sequences off a database called GISAID, the researchers told me, they reached out to the Chinese scientists who had uploaded the data to share some preliminary results. The next day, public access to the sequences was locked—according to GISAID, at the request of the Chinese researchers, who had previously analyzed the data and drawn distinctly different conclusions about what they contained.

    Yesterday evening, the international team behind the new Huanan-market analysis released a report on its findings—but did not post the underlying data. The write-up confirms that genetic material from raccoon dogs and several other mammals was found in some of the same spots at the wet market, as were bits of SARS-CoV-2’s genome around the time the outbreak began. Some of that animal genetic material, which was collected just days or weeks after the market was shut down, appears to be RNA—a particularly fast-degrading molecule. That strongly suggests that the mammals were present at the market not long before the samples were collected, making them a plausible channel for the virus to travel on its way to us. “I think we’re moving toward more and more evidence that this was an animal spillover at the market,” says Ravindra Gupta, a virologist at the University of Cambridge, who was not involved in the new research. “A year and a half ago, my confidence in the animal origin was 80 percent, something like that. Now it’s 95 percent or above.”

    For now, the report is just that: a report, not yet formally reviewed by other scientists or even submitted for publication to the journal—and that will remain the case as long as this team continues to leave space for the researchers who originally collected the market samples, many of them based at the Chinese Center for Disease Control and Prevention, to prepare a paper of their own. And still missing are the raw sequence files that sparked the reanalysis in the first place—before vanishing from the public eye.


    Every researcher I asked emphasized just how important the release of that evidence is to the origins investigation: Without data, there’s no base-level proof—nothing for the broader scientific community to independently scrutinize to confirm or refute the international team’s results. Absent raw data, “some people will say that this isn’t real,” says Gigi Gronvall, a senior scholar at the Johns Hopkins Center for Health Security, who wasn’t involved in the new analysis. Data that flicker on and off publicly accessible parts of the internet also raise questions about other clues on the pandemic’s origins. Still more evidence might be out there, yet undisclosed.

    Transparency is always an essential facet of research, but all the more so when the stakes are so high. SARS-CoV-2 has already killed nearly 7 million people, at least, and saddled countless people with chronic illness; it will kill and debilitate many more in the decades to come. Every investigation into how it began to spread among humans must be “conducted as openly as possible,” says Sarah Cobey, an infectious-disease modeler at the University of Chicago, who wasn’t involved in the new analysis.

    The team behind the reanalysis still has copies of the genetic sequences its members downloaded earlier this month. But they’ve decided that they won’t be the ones to share them, several of them told me. For one, they don’t have sequences from the complete set of samples that the Chinese team collected in early 2020—just the fraction that they spotted and grabbed off GISAID. Even if they did have all of the data, the researchers contend that it’s not their place to post them publicly. That’s up to the China CDC team that originally collected and generated the data.

    Part of the international team’s reasoning is rooted in academic decorum. There isn’t a set-in-stone guidebook among scientists, but adhering to unofficial rules on etiquette smooths successful collaborations across disciplines and international borders—especially during a global crisis such as this one. Releasing someone else’s data, the product of another team’s hard work, is a faux pas. It risks misattribution of credit, and opens the door to the Chinese researchers’ findings getting scooped before they publish a high-profile paper in a prestigious journal. “It isn’t right to share the original authors’ data without their consent,” says Niema Moshiri, a computational biologist at UC San Diego and one of the authors of the new report. “They produced the data, so it’s their data to share with the world.”

    If the international team released what data it has, it could potentially stoke the fracas in other ways. The World Health Organization has publicly indicated that the data should come from the researchers who collected them first: On Friday, at a press briefing, Tedros Adhanom Ghebreyesus, the WHO’s director-general, admonished the Chinese researchers for keeping their data under wraps for so long, and called on them to release the sequences again. “These data could have and should have been shared three years ago,” he said. And the fact that it wasn’t is “disturbing,” given just how much it might have aided investigations early on, says Gregory Koblentz, a biodefense expert at George Mason University, who wasn’t involved in the new analysis.

    Publishing the current report has already gotten the researchers into trouble with GISAID, the database where they found the genetic sequences. During the pandemic, the database has been a crucial hub for researchers sharing viral genome data; founded to provide open access to avian influenza genomes, it is also where researchers from the China CDC published the first whole-genome sequences of SARS-CoV-2, back in January 2020. A few days after the researchers downloaded the sequences, they told me, several of them were contacted by a GISAID administrator who chastised them about not being sufficiently collaborative with the China CDC team and warned them against publishing a paper using the China CDC data. They were in danger, the email said, of violating the site’s terms of use and would risk getting their database access revoked. Distributing the data to any non-GISAID users—including the broader research community—would also be a breach.

    This morning, hours after the researchers released their report online, many of them found that they could no longer log in to GISAID—they received an error message when they input their username and password. “They may indeed be accusing us of having violated their terms,” Moshiri told me, though he can’t be sure. The ban was instated with absolutely no warning. Moshiri and his colleagues maintain that they did act in good faith and haven’t violated any of the database’s terms—that, contrary to GISAID’s accusations, they reached out multiple times with offers to collaborate with the China CDC, which has “thus far declined,” per the international team’s report.

    GISAID didn’t respond when I reached out about the data’s disappearing act, its emails to the international team, and the group-wide ban. But in a statement released shortly after I contacted the database—one that echoes language in the emails sent to researchers—GISAID doubled down on accusing the international team of violating its terms of use by posting “an analysis report in direct contravention of the terms they agreed to as a condition to accessing the data, and despite having knowledge that the data generators are undergoing peer review assessment of their own publication.”

    Maria Van Kerkhove, the WHO’s COVID-19 technical lead, told me that she’s learned that the China CDC researchers recently provided a fuller data set to GISAID—more complete than the one the international team downloaded earlier this month. “It’s ready to go,” she told me. GISAID just needs permission, she said, from the Chinese researchers to make the sequences publicly available. “I reach out to them every day, asking them for a status update,” she added, but she hasn’t yet heard back on a definitive timeline. In its statement, GISAID also “strongly” suggested “that the complete and updated dataset will be made available as soon as possible,” but gave no timeline. I asked Van Kerkhove if there was a hypothetical deadline for the China CDC team to restore access, at which point the international team might be asked to publicize the data instead. “This hypothetical deadline you’re talking about? We’re way past that,” she said, though she didn’t comment specifically on whether the international team would be asked to step in. “Data has been uploaded. It is available. It just needs to be accessible, immediately.”

    Why, exactly, the sequences were first made public only so recently, and why they have yet to reappear publicly, remain unclear. In a recent statement, the WHO said that access to the data was withdrawn “apparently to allow further data updates by China CDC” to its original analysis on the market samples, which went under review for publication at the journal Nature last week. There’s no clarity, however, on what will happen if the paper is not published at all. When I reached out to three of the Chinese researchers—George Gao, William Liu, and Guizhen Wu—to ask about their intentions for the data, I didn’t receive a response.

    “We want the data to come out more than anybody,” says Saskia Popescu, an infectious-disease epidemiologist at George Mason University and one of the authors on the new analysis. Until then, the international team will be fielding accusations, already flooding in, that it falsified its analyses and overstated its conclusions.


    Researchers around the world have been raising questions about these particular genetic sequences for at least a year. In February 2022, the Chinese researchers and their close collaborators released their analysis of the same market samples probed in the new report, as well as other bits of genetic data that haven’t yet been made public. But their interpretations deviate pretty drastically from the international team’s. The Chinese team contended that any shreds of virus found at the market had most likely been brought in by infected humans. “No animal host of SARS-CoV-2 can be deduced,” the researchers asserted at the time. Although the market had perhaps been an “amplifier” of the outbreak, their analysis read, “more work involving international coordination” would be needed to determine the “real origins of SARS-CoV-2.” When reached by Jon Cohen of Science magazine last week, Gao described the sequences that fleetingly appeared on GISAID as “[n]othing new. It had been known there was illegal animal dealing and this is why the market was immediately shut down.”

    There is, then, a clear divergence between the two reports. Gao’s assessment indicates that finding animal genetic material in the market swabs merely confirms that live mammals were being illegally traded at the venue prior to January 2020. The researchers behind the new report insist that the narrative can now go a step further—they suggest not just that the animals were there, but that the animals, several of which are already known to be vulnerable to SARS-CoV-2, were there, in parts of the market where the virus was also found. That proximity, coupled with the virus’s inability to persist without a viable host, points to the possibility of an existing infection among animals, which could spark several more.

    The Chinese researchers used this same logic of location—multiple types of genetic material pulled out of the same swab—to conclude that humans were carrying around the virus at Huanan. The reanalysis confirms that there probably were infected people at the market at some point before it closed. But they were unlikely to be the virus’s only chauffeurs: Across several samples, the amount of raccoon-dog genetic material dwarfs that of humans. At one stall in particular—located in the sector of the market where the most virus-positive swabs were found—the researchers discovered at least one sample that contained SARS-CoV-2 RNA, and was also overflowing with raccoon-dog genetic material, while containing very little DNA or RNA material matching the human genome. That same stall was photographically documented housing raccoon dogs in 2014. The case is not a slam dunk: No one has yet, for instance, identified a viral sample taken from a live animal that was swabbed at the market in 2019 before the venue was closed. Still, JHU’s Gronvall told me, the situation feels clearer than ever. “All of the science is pointed” in the direction of Huanan being the pandemic’s epicenter, she said.

    To further untangle the significance of the sequences will require—you guessed it—the now-vanished genetic data. Some researchers are still withholding their judgment on the significance of the new analysis, because they haven’t gotten their hands on the genetic sequences themselves. “That’s the whole scientific process,” Van Kerkhove told me: data transparency that allows analyses to be “done and redone.”

    Van Kerkhove and others are also wondering whether more data could yet emerge, given how long this particular set went unshared. “This is an indication to me in recent days that there is more data that exists,” she said. Which means that she and her colleagues haven’t yet gotten the fullest picture of the pandemic’s early days that they could—and that they won’t be able to deliver much of a verdict until more information emerges. The new analysis does bolster the case for market animals acting as a conduit for the virus between bats (SARS-CoV-2’s likeliest original host, based on several studies on this coronavirus and others) and people; it doesn’t, however, “tell us that the other hypotheses didn’t happen. We can’t remove any of them,” Van Kerkhove told me.

    More surveillance for the virus needs to be done in wild-animal populations, she said. Having the data from the market swabs could help with that, perhaps leading back to a population of mammals that might have caught the virus from bats or another intermediary in a particular part of China. At the same time, to further investigate the idea that SARS-CoV-2 first emerged out of a laboratory mishap, officials need to conduct intensive audits and investigations of virology laboratories in Wuhan and elsewhere. Last month, the U.S. Department of Energy ruled that such an accident was the likelier catalyst of the coronavirus outbreak than a natural spillover from wild animals to humans. The ruling echoed earlier judgments from the FBI and a Senate minority report. But it contrasted with the views of four other agencies, plus the National Intelligence Council, and it was made with “low confidence” and based on “new” evidence that has yet to be declassified.

    The longer the investigation into the virus’s origins drags on, and the more distant the autumn of 2019 grows in our rearview, “the harder it becomes,” Van Kerkhove told me. Many in the research community were surprised that new information from market samples collected in early 2020 emerged at all, three years later. Settling the squabbles over SARS-CoV-2 will be especially tough because the Huanan market was so swiftly shut down after the outbreak began, and the traded animals at the venue rapidly culled, says Angela Rasmussen, a virologist at the University of Saskatchewan and one of the researchers behind the new analysis. Raccoon dogs, one of the most prominent potential hosts to have emerged from the new analysis, are not even known to have been sampled live at the market. “That evidence is gone now,” if it ever existed, Koblentz, of George Mason University, told me. For months, Chinese officials were even adamant that no mammals were being illegally sold at the region’s wet markets at all.

    So researchers continue to work with what they have: swabs from surfaces that can, at the very least, point to a susceptible animal being in the right place, at the right time, with the virus potentially inside it. “Right now, to the best of my knowledge, this data is the only way that we can actually look,” Rasmussen told me. It may never be enough to fully settle this debate. But right now, the world doesn’t even know the extent of the evidence available—or what could, or should, still emerge.

    Katherine J. Wu

    Source link

  • No One Really Knows How Much COVID Is Silently Spreading … Again

    No One Really Knows How Much COVID Is Silently Spreading … Again

    In the early days of the pandemic, one of the scariest and most surprising features of SARS-CoV-2 was its stealth. Initially assumed to transmit only from people who were actively sick—as its predecessor SARS-CoV did—the new coronavirus turned out to be a silent spreader, also spewing from the airways of people who were feeling just fine. After months of insisting that only the symptomatic had to mask, test, and isolate, officials scrambled to retool their guidance; singing, talking, laughing, even breathing in tight quarters were abruptly categorized as threats.

    Three years later, the coronavirus is still silently spreading—but the fear of its covertness again seems gone. Enthusiasm for masking and testing has plummeted; isolation recommendations have been pared down, and may soon entirely disappear. “We’re just not communicating about asymptomatic transmission anymore,” says Saskia Popescu, an infectious-disease epidemiologist and infection-prevention expert at George Mason University. “People think, What’s the point? I feel fine.

    Although the concern over asymptomatic spread has dissipated, the threat itself has not. And even as our worries over the virus continue to shrink and be shunted aside, the virus—and the way it moves between us—is continuing to change. Which means that our best ideas for stopping its spread aren’t just getting forgotten; they’re going obsolete.

    When SARS-CoV-2 was new to the world and hardly anyone had immunity, symptomless spread probably accounted for most of the virus’s spread—at least 50 percent or so, says Meagan Fitzpatrick, an infectious-disease transmission modeler at the University of Maryland’s School of Medicine. People wouldn’t start feeling sick until four, five, or six days, on average, after being infected. In the interim, the virus would be xeroxing itself at high speed in their airway, reaching potentially infectious levels a day or two before symptoms started. Silently infected people weren’t sneezing and coughing—symptoms that propel the virus more forcefully outward, increasing transmission efficiency. But at a time when tests were still scarce and slow to deliver results, not knowing they had the virus made them dangerous all the same. Precautionary tests were still scarce, or very slow to deliver results. So symptomless transmission became a norm, as did epic superspreading events.

    Now, though, tests are more abundant, presymptomatic spread is a better-known danger, and repeated rounds of vaccination and infection have left behind layers of immunity. That protection, in particular, has slashed the severity and duration of acute symptoms, lowering the risk that people will end up in hospitals or morgues; it may even be chipping away at long COVID. At the same time, though, the addition of immunity has made the dynamics of symptomless transmission much more complex.

    On an individual basis, at least, silent spread could be happening less often than it did before. One possible reason is that symptoms are now igniting sooner in people’s bodies, just three or so days, on average, after infection—a shift that roughly coincided with the rise of the first Omicron variant and could be a quirk of the virus itself. But Aubree Gordon, an infectious-disease epidemiologist at the University of Michigan, told me that faster-arriving sicknesses are probably being driven in part by speedier immune responses, primed by past exposures. That means that illness might now coincide with or even precede the peak of contagiousness, shortening the average period in which people spread the virus before they feel sick. In that one very specific sense, COVID could now be a touch more flulike. Presymptomatic transmission of the flu does seem to happen on occasion, says Seema Lakdawala, a virologist at Emory University. But in general, “people tend not to hit their highest viral levels until after they develop symptoms,” Gordon told me.

    Coupled with more population-level immunity, this arrangement could be working in our favor. People might be less likely to pass the virus unwittingly to others. And thanks to the defenses we’ve collectively built up, the pathogen itself is also having more trouble exiting infected bodies and infiltrating new ones. That’s almost certainly part of the reason that this winter hasn’t been quite as bad as past ones have, COVID-wise, says Maia Majumder, an infectious-disease modeler at Harvard Medical School and Boston Children’s Hospital.

    That said, a lot of people are still undoubtedly catching the coronavirus from people who aren’t feeling sick. Infection per infection, the risk of superspreading events might now be lower, but at the same time people have gotten chiller about socializing without masks and testing before gathering in groups—a behavioral change that’s bound to counteract at least some of the forward shift in symptoms. Presymptomatic spread might be less likely nowadays, but it’s nowhere near gone. Multiply a small amount of presymptomatic spread by a large number of cases, and that can still seed … another large number of cases.

    There could be some newcomers to the pool of silent spreaders, too—those who are now transmitting the virus without ever developing symptoms at all. With people’s defenses higher than they were even a year and a half ago, infections that might have once been severe are now moderate or mild; ones that might have once been mild are now unnoticeable, says Seyed Moghadas, a computational epidemiologist at York University. At the same time, though, immunity has probably transformed some symptomless-yet-contagious infections into non-transmissible cases, or kept some people from getting infected at all. Milder cases are of course welcome, Fitzpatrick told me, but no one knows exactly what these changes add up to: Depending on the rate and degree of each of those shifts, totally asymptomatic transmission might now be more common, less common, or sort of a wash.

    Better studies on transmission patterns would help cut through the muck; they’re just not really happening anymore. “To get this data, you need to have pretty good testing for surveillance purposes, and that basically has stopped,” says Yonatan Grad, an infectious-disease epidemiologist at Harvard’s School of Public Health.

    Meanwhile, people are just straight-up testing less, and rarely reporting any of the results they get at home. For many months now, even some people who are testing have been seeing strings of negative results days into bona-fide cases of COVID—sometimes a week or more past when their symptoms start. That’s troubling on two counts: First, some legit COVID cases are probably getting missed, and keeping people from accessing test-dependent treatments such as Paxlovid. Second, the disparity muddles the start and end of isolation. Per CDC guidelines, people who don’t test positive until a few days into their illness should still count their first day of symptoms as Day 0 of isolation. But if symptoms might sometimes outpace contagiousness, “I think those positive tests should restart the isolation clock,” Popescu told me, or risk releasing people back into society too soon.

    American testing guidelines, however, haven’t undergone a major overhaul in more than a year—right after Omicron blew across the nation, says Jessica Malaty Rivera, an infectious-disease epidemiologist at Boston Children’s Hospital. And even if the rules were to undergo a revamp, they wouldn’t necessarily guarantee more or better testing, which requires access and will. Testing programs have been winding down for many months; free diagnostics are once again growing scarce.

    Through all of this, scientists and nonscientists alike are still wrestling with how to define silent infection in the first place. What counts as symptomless depends not just on biology, but behavior—and our vigilance. As worries over transmission continue to falter and fade, even mild infections may be mistaken for quiet ones, Grad told me, brushed off as allergies or stress. Biologically, the virus and the disease may not need to become that much more muted to spread with ease: Forgetting about silent spread may grease the wheels all on its own.

    Katherine J. Wu

    Source link

  • Somehow, the Science on Masks Still Isn’t Settled

    Somehow, the Science on Masks Still Isn’t Settled

    For many Americans, wearing a mask has become a relic. But fighting about masks, it seems, has not.

    Masking has widely been seen as one of the best COVID precautions that people can take. Still, it has sparked ceaseless arguments: over mandates, what types of masks we should wear, and even how to wear them. A new review and meta-analysis of masking studies suggests that the detractors may have a point. The paper—a rigorous assessment of 78 studies—was published by Cochrane, an independent policy institution that has become well known for its reviews. The review’s authors found “little to no” evidence that masking at the population level reduced COVID infections, concluding that there is “uncertainty about the effects of face masks.” That result held when the researchers compared surgical masks with N95 masks, and when they compared surgical masks with nothing.

    On Twitter, longtime critics of masking and mandates held this up as the proof they’d long waited for. The Washington Free Beacon, a conservative outlet, quoted a researcher who has called the analysis the “scientific nail in the coffin for mask mandates.” The vaccine skeptic Robert Malone used it to refute what he called “self-appointed ‘experts’” on masking. Some researchers weighed in with more nuanced interpretations, pointing out limitations in the review’s methods that made it difficult to draw firm conclusions. Even the CDC director, Rochelle Walensky, pushed back against the paper in a congressional testimony this week, citing its small sample size of COVID-specific studies. The argument is heated and technical, and probably won’t be resolved anytime soon. But the fact that the fight is ongoing makes clear that there still isn’t a firm answer to among the most crucial of pandemic questions: Just how effective are masks at stopping COVID?

    An important feature of Cochrane reviews is that they look only at “randomized controlled trials,” considered the gold standard for certain types of research because they compare the impact of one intervention with another while tightly controlling for biases and confounding variables. The trials considered in the review compared groups of people who masked with those who didn’t in an effort to estimate how effective masking is at blunting the spread of COVID in a general population. The population-level detail is important: It indicates uncertainty about whether requiring everyone to wear a mask makes a difference in viral spread. This is different from the impact of individual masking, which has been better researched. Doctors, after all, routinely mask when they’re around sick patients and do not seem to be infected more often than anyone else. “We have fairly decent evidence that masks can protect the wearer,” Jennifer Nuzzo, an epidemiologist at Brown University, told me. “Where I think it sort of falls apart is relating that to the population level.”

    The research on individual masking generally shows what we have come to expect: High-quality masks provide a physical barrier between the wearer and infectious particles, if worn correctly. For instance, in one study, N95 masks were shown to block 57 to 90 percent of particles, depending on how well they fit; cloth and surgical masks are less effective. The caveat is that much of that support came from laboratory research and observational studies, which don’t account for the messiness of real life.

    That the Cochrane review reasonably challenges the effectiveness of population-level masking doesn’t mean the findings of previous studies in support of masking are moot. A common theme among criticisms of the review is that it considered only a small number of studies by virtue of Cochrane’s standards; there just aren’t that many randomized controlled trials on COVID and masks. In fact, most of those included in the review are about the impact of masking on other respiratory illnesses, namely the flu. Although some similarities between the viruses are likely, Nuzzo explained on Twitter, COVID-specific trials would be ideal.

    The handful of trials in the review that focus on COVID don’t show strong support for masking. One, from Bangladesh, which looked at both cloth and surgical masks, found a 9 percent decrease in symptomatic cases in masked versus unmasked groups (and a reanalysis of that study found signs of bias in the way the data were collected and interpreted); another, from Denmark, suggested that surgical masks offered no statistically significant protection at all.

    Criticisms of the review posit that it might have come to a different conclusion if more and better-quality studies had been available. The paper’s authors acknowledge that the trials they considered were prone to bias and didn’t control for inconsistent adherence to the interventions. “The low to moderate certainty of evidence means our confidence in the effect estimate is limited, and that the true effect may be different from the observed estimate of the effect,” they concluded. If high-quality masks worn properly work well at an individual level, after all, then it stands to reason that  high-quality masks worn properly by many people in any situation should indeed provide some level of protection.

    Tom Jefferson, the review’s lead author, did not respond to a request for comment. But in a recent interview about the controversy, he stood by the practical implications of the new study. “There’s still no evidence that masks are effective during a pandemic,” he said.

    Squaring all of this uncertainty with the support for masking and mandates early in the pandemic is difficult. Evidence for it was scarce in the early days of the pandemic, Nuzzo acknowledged, but health officials had to act. Transmission was high, and the costs of masking were seen as low; it was not immediately clear how inconvenient and unmanageable masks could be, especially in settings such as schools. Mask mandates have largely expired in most places, but it doesn’t hurt most people to err on the side of caution. Nuzzo still wears a mask in high-risk environments. “Will that prevent me from ever getting COVID? No,” she said, but it reduces her risk—and that’s good enough.

    What is most frustrating about this masking uncertainty is that the pandemic has presented many opportunities for the U.S. to gather stronger data on the effects of population-level masking, but those studies have not happened. Masking policies were made on sound but limited data, and when decisions are made that way, “you need to continually assess whether those assumptions are correct,” Nuzzo said—much like how NASA collects huge amounts of data to prepare for all the things that could go wrong with a shuttle launch. Unfortunately, she said, “we don’t have Houston for the pandemic.”

    Obtaining stronger data is still possible, though it won’t be easy. A major challenge of studying the effect of population-level masking in the real world is that people aren’t good at wearing masks, which of course is a problem with the effectiveness of masks too. It would be straightforward enough if you could guarantee that participants wore their masks perfectly and consistently throughout the study period. But in the real world, masks fit poorly and slip off noses, and people are generally eager to take them off whenever possible.

    Ideally, the research needed to gather strong data—about masks, and other lingering pandemic questions—would be conducted through the government. The U.K., for example, has funded large randomized controlled trials of COVID drugs such as molnupiravir. So far, that doesn’t seem to have happened in the U.S.  None of the new studies on masking included in the Cochrane review were funded by the U.S. government. “The fact that we never as a country really set up studies to answer the most pressing questions is a failure,” said Nuzzo. What the CDC could do is organize and fund a research network to study COVID, much like the centers of excellence the agency has for fields such as food safety and tuberculosis.

    The window of opportunity hasn’t closed yet. The Cochrane review, for all of its controversy, is a reminder that more research on masking is needed, if only to address whether pro-mask policies warrant the rage they incite. You would think that the policy makers who encouraged masking would have made finding that support a priority. “If you’re going to burn your political capital, it’d be nice to have the evidence to say that it’s necessary,” Nuzzo said.

    At this point, even the strongest possible evidence is unlikely to change some people’s behavior, considering how politicized the mask debate has become. But as a country, the lack of conclusive evidence leaves us ill-prepared for the next viral outbreak—COVID or otherwise. The risk is still low, but bird flu is showing troubling signs that it could make the jump from animals to humans. If it does, should officials be telling everyone to mask up? That America has never amassed good evidence to show the effect of population-level masking for COVID, Nuzzo said, has been a missed opportunity. The best time to learn more about masking is before we are asked to do it again.

    Yasmin Tayag

    Source link

  • Was the COVID Toilet Panic Overblown?

    Was the COVID Toilet Panic Overblown?

    In the dark early days of the pandemic, when we knew almost nothing and feared almost everything, there was a moment when people became very, very worried about toilets. More specifically, they were worried about the possibility that the cloud of particles toilets spew into the air when flushed—known in the scientific literature as “toilet plume”—might be a significant vector of COVID transmission. Because the coronavirus can be found in human excrement, “flushing the toilet may fling coronavirus aerosols all over,” The New York Times warned in June 2020. Every so often in the years since, the occasional PSA from a scientist or public-health expert has renewed the scatological panic.

    In retrospect, so much of what we thought we knew in those early days was wrong. Lysoling our groceries turned out to not be helpful. Masking turned out to be very helpful. Hand-washing, though still important, was not all it was cracked up to be, and herd immunity, in the end, was a mirage. As the country shifts into post-pandemic life and takes stock of the past three years, it’s worth asking: What really was the deal with toilet plume?

    The short answer is that our fears have not been substantiated, but they weren’t entirely overblown either. Scientists have been studying toilet plume for decades. They’ve found that plumes vary in magnitude depending on the type of toilet and flush mechanism. Flush energy plays a role too: The greater it is, the larger the plume. Closing the lid (if the toilet has one) helps a great deal, though even that cannot completely eliminate toilet plume—particles can still escape through the gap between the seat and the lid.

    Whatever the specifics, the main conclusion from years of research preceding the pandemic has been consistent and disgusting: “Flush toilets produce substantial quantities of toilet plume aerosol capable of entraining microorganisms at least as large as bacteria … These bioaerosols may remain viable in the air for extended periods and travel with air currents,” scientists at the CDC and the University of Oklahoma College of Public Health wrote in a 2013 review paper titled “Lifting the Lid on Toilet Plume Aerosol.” In other words, when you flush a toilet, an unsettling amount of the contents go up rather than down.

    Knowing this is one thing; seeing it is another. Traditionally, scientists have measured toilet plume with either a particle counter or, in at least one case, “a computational model of an idealized toilet.” But in a new study published last month, researchers at the University of Colorado at Boulder took things a step further, using bright-green lasers to render visible what usually, blessedly, is not. John Crimaldi, an engineering professor and a co-author of the study, who has spent 25 years using lasers to illuminate invisible phenomena, told me that he and his colleagues went into the experiment fully expecting to see something. Even so, they were “completely caught off guard” by the results. The plume was bigger, faster, and more energetic than they’d anticipated—“like an eruption,” Crimaldi said, or, as he and his colleagues put it in their paper, a “strong chaotic jet.”

    Within eight seconds, the resulting cloud of aerosols shoots nearly five feet above the toilet bowl—that is, more than six feet above the ground. That is: straight into your face. After the initial burst, the plume continues to rise until it hits the ceiling, and then it wafts outward. It meets a wall and runs along it. Before long, it fills the room. Once that happens, it hangs around for a while. “You can sort of extrapolate in your own mind to walking into a public restroom in an airport that has 20 toilet stalls, all of them flushing every couple minutes,” Crimaldi said. Not a pleasant thought.

    The question, then, is not so much whether toilet plume happens—like it or not, it clearly does—as whether it presents a legitimate transmission risk of COVID or anything else. This part is not so clear. The 2013 review paper identified studies of the original SARS virus as “among the most compelling indicators of the potential for toilet plume to cause airborne disease transmission.” (The authors also noted, in a dry aside, that although SARS was “not presently a common disease, it has demonstrated its potential for explosive spread and high mortality.”) The one such study the authors discuss explicitly is a report on the 2003 outbreak in Hong Kong’s Amoy Gardens apartment complex. That study, though, is far from conclusive, Mark Sobsey, an environmental microbiologist at the University of North Carolina at Chapel Hill, told me. The researchers didn’t rule out other modes of transmission, nor did they attempt to culture live virus from the fecal matter—a far more reliable indicator of infectiousness than mere detection.

    Beyond that, Sobsey said, there is little evidence that toilet plumes spread SARS or COVID-19. In his own review, published in December 2021, Sobsey found “no documented evidence” of viral transmission via fecal matter. This, at least, seems to track with the three years of pandemic experience we’ve all now endured. Although we can’t easily prove that bathrooms don’t play a significant role in spreading COVID-19, we haven’t seen any glaring indications that they do. And anyway, the coronavirus has found plenty of other awful ways to spread.

    Just because toilet plume doesn’t seem to be a vector of COVID transmission, though, doesn’t mean you can forget about it. Gastrointestinal viruses such as norovirus, Sobsey told me, present a more serious risk of transmission via toilet plume, because they are known to spread via fecal matter. The only real solutions are structural. Improved ventilation would keep aerosolized waste from building up in the air, and germicidal lighting, though the technology is still being developed, could potentially disinfect what remains. Neither, however, would stop the plume in the first place. To do that, you would need to change the toilet itself: In order to create a smoother and thus better-contained flush, you could change the geometry of the bowl, the way the water enters and exits, or any number of other variables. Toilet manufacturers could also, you know, stop producing lidless toilets.

    But none of that will save you the next time you find yourself staring into a toilet’s blank maw. Crimaldi suggests wearing a mask in public bathrooms to protect against not just the plume created when you flush but also the plumes left by the person who used the bathroom before you, the person who used it before them, and so on. You don’t need to have any great affection for masking as a public-health intervention to consider donning one for a few minutes to avoid literally breathing in shit. Sobsey offered another bit of unconventional bathroom-hygiene advice, which he acknowledged can only do so much to protect you: If you find yourself in a public restroom with a lidless toilet, he said, consider washing your hands before you flush. Then “hold your breath, flush the toilet, and leave.”

    Jacob Stern

    Source link

  • The ‘End’ of COVID Is Still Far Worse Than We Imagined

    The ‘End’ of COVID Is Still Far Worse Than We Imagined

    When is the pandemic “over”? In the early days of 2020, we envisioned it ending with the novel coronavirus going away entirely. When this became impossible, we hoped instead for elimination: If enough people got vaccinated, herd immunity might largely stop the virus from spreading. When this too became impossible, we accepted that the virus would still circulate but imagined that it could become, optimistically, like one of the four coronaviruses that cause common colds or, pessimistically, like something more severe, akin to the flu.

    Instead, COVID has settled into something far worse than the flu. When President Joe Biden declared this week, “The pandemic is over. If you notice, no one’s wearing masks,” the country was still recording more than 400 COVID deaths a day—more than triple the average number from flu.

    This shifting of goal posts is, in part, a reckoning with the biological reality of COVID. The virus that came out of Wuhan, China, in 2019 was already so good at spreading—including from people without symptoms—that eradication probably never stood a chance once COVID took off internationally. “I don’t think that was ever really practically possible,” says Stephen Morse, an epidemiologist at Columbia. In time, it also became clear that immunity to COVID is simply not durable enough for elimination through herd immunity. The virus evolves too rapidly, and our own immunity to COVID infection fades too quickly—as it does with other respiratory viruses—even as immunity against severe disease tends to persist. (The elderly who mount weaker immune responses remain the most vulnerable: 88 percent of COVID deaths so far in September have been in people over 65.) With a public weary of pandemic measures and a government reluctant to push them, the situation seems unlikely to improve anytime soon. Trevor Bedford, a virologist at the Fred Hutchinson Cancer Center, estimates that COVID will continue to exact a death toll of 100,000 Americans a year in the near future. This too is approximately three times that of a typical flu year.


    I keep returning to the flu because, back in early 2021, with vaccine excitement still fresh in the air, several experts told my colleague Alexis Madrigal that a reasonable threshold for lifting COVID restrictions was 100 deaths a day, roughly on par with flu. We largely tolerate, the thinking went, the risk of flu without major disruptions to our lives. Since then, widespread immunity, better treatments, and the less virulent Omicron variant have together pushed the risk of COVID to individuals down to a flu-like level. But across the whole population, COVID is still killing many times more people than influenza is, because it is still sickening so many more people.

    Bedford told me he estimates that Omicron has infected 80 percent of Americans. Going forward, COVID might continue to infect 50 percent of the population every year, even without another Omicron-like leap in evolution. In contrast, flu sickens an estimated 10 to 20 percent of Americans a year. These are estimates, because lack of testing hampers accurate case counts for both diseases, but COVID’s higher death toll is a function of higher transmission. The tens of thousands of recorded cases—likely hundreds of thousands of actual cases every day—also add to the burden of long COVID.

    The challenge of driving down COVID transmission has also become clearer with time. In early 2021, the initially spectacular vaccine-efficacy data bolstered optimism that vaccination could significantly dampen transmission. Breakthrough cases were downplayed as very rare. And they were—at first. But immunity to infection is not durable against common respiratory viruses. Flu, the four common-cold coronaviruses, respiratory syncytial virus (RSV), and others all reinfect us over and over again. The same proved true with COVID. “Right at the beginning, we should have made that very clear. When you saw 95 percent against mild disease, with the trials done in December 2020, we should have said right then this is not going to last,” says Paul Offit, the director of the Vaccine Education Center at Children’s Hospital of Philadelphia. Even vaccinating the whole world would not eliminate COVID transmission.

    This coronavirus has also proved a wilier opponent than expected. Despite a relatively slow rate of mutation at the beginning of the pandemic, it soon evolved into variants that are more inherently contagious and better at evading immunity. With each major wave, “the virus has only gotten more transmissible,” says Ruth Karron, a vaccine researcher at Johns Hopkins. The coronavirus cannot keep becoming more transmissible forever, but it can keep changing to evade our immunity essentially forever. Its rate of evolution is much higher than that of other common-cold coronaviruses. It’s higher than that of even H3N2 flu—the most troublesome and fastest-evolving of the influenza viruses. Omicron, according to Bedford, is the equivalent of five years of H3N2 evolution, and its subvariants are still outpacing H3N2’s usual rate. We don’t know how often Omicron-like events will happen. COVID’s rate of change may eventually slow down when the virus is no longer novel in humans, or it may surprise us again.

    In the past, flu pandemics “ended” after the virus swept through so much of the population that it could no longer cause huge waves. But the pandemic virus did not disappear; it became the new seasonal-flu virus. The 1968 H3N2 pandemic, for example, seeded the H3N2 flu that still sickens people today. “I suspect it’s probably caused even more morbidity and mortality in all those years since 1968,” Morse says. The pandemic ended, but the virus continued killing people.

    Ironically, H3N2 did go away during the coronavirus pandemic. Measures such as social distancing and masking managed to almost entirely eliminate the flu. (It has not disappeared entirely, though, and may be back in full force this winter.) Cases of other respiratory viruses, such as RSV, also plummeted. Experts hoped that this would show Americans a new normal, where we don’t simply tolerate the flu and other respiratory illnesses every winter. Instead, the country is moving toward a new normal where COVID is also something we tolerate every year.

    In the same breath that President Biden said, “The pandemic is over,” he went on to say, “We still have a problem with COVID. We’re still doing a lot of work on it.” You might see this as a contradiction, or you might see it as how we deal with every other disease—an attempt at normalizing COVID, if you will. The government doesn’t treat flu, cancer, heart disease, tuberculosis, hepatitis C, etc., as national emergencies that disrupt everyday life, even as the work continues on preventing and treating them. The U.S.’s COVID strategy certainly seems to be going in that direction. Broad restrictions such as mask mandates are out of the question. Interventions targeted at those most vulnerable to severe disease exist, but they aren’t getting much fanfare. This fall’s COVID-booster campaign has been muted. Treatments such as bebtelovimab and Evusheld remain on shelves, underpublicized and underused.

    At the same time, hundreds of Americans are still dying of COVID every day and will likely continue to die of COVID every day. A cumulative annual toll of 100,000 deaths a year would still make COVID a top-10 cause of death, ahead of any other infectious disease. When the first 100,000 Americans died of COVID, in spring 2020, newspapers memorialized the grim milestone. The New York Times devoted its entire front page to chronicling the lives lost to COVID. It might have been hard to imagine, back in 2020, that the U.S. would come to accept 100,000 people dying of COVID every year. Whether or not that means the pandemic is over, the second part of the president’s statement is harder to argue with: COVID is and will remain a problem.

    Sarah Zhang

    Source link

  • What Comes After the Search Warrant?

    What Comes After the Search Warrant?

    If Donald Trump committed crimes on his way out of the White House, he should be subject to the same treatment as any other alleged criminal. The reason for this is simple: Ours is a government of laws, not of men, as John Adams once observed. Nobody, not even a president, is above those laws.

    So why did I feel nauseous yesterday, watching coverage of the FBI executing a search warrant at Trump’s Mar-a-Lago estate?

    Because this country is tracking toward a scale of political violence not seen since the Civil War. It’s evident to anyone who spends significant time dwelling in the physical or virtual spaces of the American right. Go to a gun show. Visit a right-wing church. Check out a Trump rally. No matter the venue, the doomsday prophesying is ubiquitous—and scary. Whenever and wherever I’ve heard hypothetical scenarios of imminent conflict articulated, the premise rests on an egregious abuse of power, typically Democrats weaponizing agencies of the state to target their political opponents. I’ve always walked away from these experiences thinking to myself: If America is a powder keg, then one overreach by the government, real or perceived, could light the fuse.

    Think I’m being hysterical? I’ve been accused of that before. But we’ve seen what happens when millions of Americans abandon their faith in the nation’s core institutions. We’ve seen what happens when millions of Americans become convinced that their leaders are illegitimate. We’ve seen what happens when millions of Americans are manipulated into believing that Trump is suffering righteously for their sake; that an attack on him is an attack on them, on their character, on their identity, on their sense of sovereignty. And I fear we’re going to see it again.

    It’s tempting to think of January 6, 2021, as but one day in our nation’s history. It’s comforting to view the events of that day—the president inciting a violent mob to storm the U.S. Capitol and attempt to overturn the results of a free and fair election—as the result of unprecedented conditions that happened to converge all at once, conditions that are not our national norm.

    But perhaps we should view January 6 as the beginning of a new chapter.

    It’s worth remembering that Trump, who has long claimed to be a victim of political persecution, threatened to jail his opponent, Hillary Clinton, throughout the 2016 campaign, reveling in chants of “Lock her up!” at rallies nationwide. (Republicans did not cry foul when the FBI announced an investigation into Clinton just days before the election.) It was during that campaign—as I traveled the country talking with Republican voters, hoping to understand the Trump phenomenon—that I began hearing casual talk of civil war. Those conversations were utterly jarring. People spoke matter-of-factly about amassing arms. Many were preparing for a day when, in their view, violence would become unavoidable.

    I remember talking with Lee Stauffacher, a 65-year-old Navy veteran, outside an October Trump rally in Arizona. “I’ve watched this country deteriorate from the law-and-order America I loved into a country where certain people are above the law,” Stauffacher said. “Hillary Clinton is above the law. Illegal immigrants are above the law. Judges have stopped enforcing the laws they don’t agree with.”

    Stauffacher went on about his fondness of firearms and his loathing of the Democratic Party. “They want to turn this into some communist country,” he said. “I say, over my dead body.”

    This sort of rhetoric cooled, for a time, after Trump’s victory. But then came Special Counsel Robert Mueller’s investigation into Russian election interference and possible collusion. And the subsequent arrests of some of the president’s closest confidants. Then came the first impeachment of Trump himself. By the time his reelection campaign got under way, Trump was fashioning himself a wartime president, portraying himself on the front lines of a pitched battle between decent, patriotic Americans and a “deep state” of government thugs who aim to enforce conformity and silence dissent.

    On December 18, 2019, the day he was impeached for the first time, Trump tweeted a black-and-white photo that showed him pointing into the camera. “THEY’RE NOT AFTER ME … THEY’RE AFTER YOU,” read the caption. “I’M JUST IN THE WAY.”

    As I hit the road again in 2020, crisscrossing the nation to get a read on the Republican base, it was apparent that something had changed. There was plenty of that same bombast, all the usual chesty talk of people taking matters into their own hands. But whereas once the rhetoric had felt scattered—rooted in grievances against the left, or opposition to specific laws, or just general discomfort with a country they no longer recognized—the new threats seemed narrow and targeted. Voter after voter told me there had been a plot to sabotage Trump’s presidency from the start, and now there was a secretive plot to stop him from winning a second term. Everyone in government—public-health officials, low-level bureaucrats, local election administrators—was in on it. The goal wasn’t to steal the election from Trump; it was to steal the election from them.

    “They’ve been trying to cheat us from the beginning,” Deborah Fuqua-Frey told me outside a Ford plant in Michigan that Trump was visiting during the early days of the pandemic. “First it was Mueller, then it was Russia. Isn’t it kind of convenient that as soon as impeachment failed, we’ve suddenly got this virus?”

    I asked her to elaborate.

    “The deep state,” she said. “This was domestic political terrorism from the Democratic Party.”

    This kind of thinking explains why countless individuals would go on to donate their hard-earned money—more than $250 million in total—to an “Election Defense Fund” that didn’t exist. It explains why others swarmed vote-counting centers, intimidated poll workers, signed on to shoddy legal efforts, flocked to fringe voices advocating solutions such as martyrdom and secession from the union, threatened to kill elections officials, boarded buses to Washington, and ultimately stormed the United States Capitol.

    What made January 6 so predictable—the willingness of Republican leaders to prey on the insecurities and outright paranoia of these voters—is what makes August 8 so dangerous.

    “The Obama FBI began spying on President Trump as a candidate,” Senator Marsha Blackburn of Tennessee tweeted this morning. “If they can do this to Trump, they will do it to you!”

    “If they can do it to a former President, imagine what they can do to you,” read a tweet from Republicans on the House Judiciary Committee. They followed up: “The IRS is coming for you. The DOJ is coming for you. The FBI is coming for you. No one is safe from political punishment in Joe Biden’s America.”

    “If there was any doubt remaining, we are now living in a post constitutional America where the Justice Department has been weaponized against political threats to the regime, as it would in a banana republic,” the Texas Republican Party tweeted. “It won’t stop with Trump. You are next.”

    It won’t stop with Trump—that much is certain. The House Republican leader, Kevin McCarthy, all but promised retaliation against the Justice Department should his party retake the majority this fall. Investigations of President Joe Biden and his son Hunter were already more or less guaranteed; the question now becomes how wide of a net congressional Republicans, in their eagerness to exact vengeance on behalf of Trump and appease a fuming base, cast in probing other people close to the president and his administration.

    Assuming that Trump runs in 2024, the stakes are even higher. If Biden—or another Democrat—defeats him, Republicans will have all the more reason to reject the results, given what they see as the Democrats’ politically motivated investigation of the likely Republican nominee. If Trump wins, he and his hard-line loyalists will set about purging the DOJ, the intelligence community, and other vital government departments of careerists deemed insufficiently loyal. There will be no political cost to him for doing so; a Trump victory will be read as a mandate to prosecute his opponents. Indeed, that seems to be exactly where we’re headed.

    “Biden is playing with fire by using a document dispute to get the @TheJusticeDept to persecute a likely future election opponent,” Senator Marco Rubio of Florida tweeted. “Because one day what goes around is going to come around.”

    And then what? It feels lowest-common-denominator lazy, in such uncertain times, to default to speculation of 1860s-style secession and civil war. But it’s clearly on the minds of Americans. Last year, a poll from the University of Virginia showed that a majority of Trump voters (52 percent) and a strong minority of Biden voters (41 percent) strongly or somewhat agreed that America is so fractured, they would favor red and blue states seceding from the union to form their own countries. Meanwhile, a poll from The Washington Post and the University of Maryland showed that one in three Americans believes violence against the government is justified, and a separate poll by NPR earlier this year showed that one in 10 Americans believes violence is justified “right now.”

    It’s hard to see how any of this gets better. But it’s easy to see how it gets much, much worse.

    We don’t know exactly what the FBI was looking for at Mar-a-Lago. We don’t know what was found. What we must acknowledge—even those of us who believe Trump has committed crimes, in some cases brazenly so, and deserves full prosecution under the law—is that bringing him to justice could have some awful consequences.

    Is that justice worth the associated risks? Yesterday, the nation’s top law-enforcement officers decided it was. We can only hope they were correct.

    Tim Alberta

    Source link